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Abstract Studies about formaldehyde (FA) published
since the guideline of 0.1 mg/m3 by the World Health
Organization (WHO) in 2010 have been evaluated; critical
effects were eye and nasal (portal-of-entry) irritation. Also,
it was considered to prevent long-term effects, including all
types of cancer. The majority of the recent toxicokinetic
studies showed no exposure-dependent FA–DNA adducts
outside the portal-of-entry area and FA–DNA adducts at
distant sites were due to endogenously generated FA. The
no-observed-adverse-effect level for sensory irritation was
0.5 ppm and recently reconfirmed in hypo- and hypersen-
sitive individuals. Investigation of the relationship between
FA exposure and asthma or other airway effects in children
showed no convincing association. In rats, repeated expo-
sures showed no point mutation in the p53 and K-Ras genes
at B15 ppm neither increased cell proliferation, histopa-
thological changes and changes in gene expression at
0.7 ppm. Repeated controlled exposures (0.5 ppm with
peaks at 1 ppm) did not increase micronucleus formation in
human buccal cells or nasal tissue (0.7 ppm) or in vivo
genotoxicity in peripheral blood lymphocytes (0.7 ppm),
but higher occupational exposures were associated with
genotoxicity in buccal cells and cultivated peripheral blood
lymphocytes. It is still valid that exposures not inducing
nasal squamous cell carcinoma in rats will not induce
nasopharyngeal cancer or lymphohematopoietic malig-
nancies in humans. Reproductive and developmental tox-
icity are not considered relevant in the absence of sensory
irritation. In conclusion, the WHO guideline has been
strengthened.
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Introduction
Formaldehyde (FA), a high-volume chemical, is ubiqui-
tously found in the environment due to natural sources and
anthropogenic activities. Major indoor air sources are
building materials (e.g. wooden products as furniture,
particleboard, plywood and medium-density fibreboard),
consumer products and combustion processes (WHO
2010). The International Agency for Research on Cancer
(IARC) has classified FA in group 1 (human carcinogen). It
was based on inhalation causing squamous cell carcinoma
(SCC) in rats and nasopharyngeal cancer in humans (IARC
2006). Recently, the classification has been expanded with
FA causing leukaemia and limited evidence of sinonasal
cancer in humans (IARC 2012).
Indoor air is the dominating contributor to FA exposure
through inhalation. Therefore, the World Health Organi-
zation (WHO) developed an indoor air guideline value in
2010. The critical effects were considered the portal-
of-entry effects, sensory irritation of the eyes and the upper
airways, resulting in a guideline value of 0.1 mg/m3 that
should not be exceeded for any 30-min period of the day
(WHO 2010). The guideline intends to prevent sensory
irritation after acute and chronic exposures and cancer at
the portal-of-entry as well as at remoter sites. In this
review, we evaluate the literature published since the
guideline was published with the purpose to evaluate
whether the guideline has been compromised.
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Exposures
In Europe, Canada and the US, the general FA levels
(geometric mean, median or average concentrations) in
homes or dwellings were generally within 20–40 lg/m3,
the 95th percentiles were roughly two times higher. In
Japan, a recent study suggests a similar mean level. A
higher mean concentration has been reported in China
(*240 lg/m3). In Europa and the US, the general levels in
public buildings and office buildings were lower than in
homes and dwellings. Mean ambient outdoor concentra-
tions were typically in the range 1–4 lg/m3, but with
higher levels in polluted cities (WHO 2010). Other
examples from recent reports support the WHO exposure
data. Exposure levels from the comprehensive review by
Salthammer et al. (2010) showed that the general level in
homes and dwellings in Europe, Canada and the US were
overall similar to the range reported by WHO (2010),
although slightly broader (10–80 lg/m3); the 95th per-
centiles were mostly B100 lg/m3. Another recent review
reported FA levels in Europe to be typically between 10
and 50 lg/m3. The maximum concentration was in general
\100 lg/m3. The concentration inside cars was about
15 lg/m3 with a maximum of 27 lg/m3 in dense traffic
(Sarigiannis et al. 2011).
In France, the median FA concentration was 20 lg/m3
(10th and 95th percentile: 9 and 47 lg/m3) in dwellings
and 14 lg/m3 (min and max: 1.5 and 56 lg/m3) in the day-
care centres. The mean concentration was 27 lg/m3 (min
and max: 4 and 100 lg/m3) in schools and 16 lg/m3 (min
and max: 7 and 27 lg/m3) in cars (Mandin et al. 2012).
Mean concentrations in Turkish primary school classrooms
and kindergartens were in the range from 19 to 109 lg/m3,
and at outdoor playgrounds from 0.6 to 9 lg/m3 (Sofuoglu
et al. 2011). Recent measurements in Japanese dwellings
aged B7 years showed a decrease in indoor air FA con-
centrations compared with previous measurements. The
25th, the median and the 75th percentile was 34, 49 and
67 lg/m3 FA, respectively, in homes with occupants
reporting sick-building syndrome (SBS) symptoms and 27,
40 and 56 lg/m3 FA, respectively, among non-SBS
reporting participants. Although the differences between
the two types of homes were marginal, the differences were
statistically different (p \ 0.001) (Takigawa et al. 2010). In
Houston metropolis, a highly industrial area in the US, the
average ambient FA concentration was about 3–7 ppb
(*4–9 lg/m3) with peak exposures up to 37 ppb (45
lg/m3) (Guven and Olaguer 2011); we use the conversion
factor: 1 ppm is equal to 1.228 mg/m3 at 25 C and 1 atm
throughout the studies. Low rural FA concentrations have
been confirmed in a study from the northern Michigan. FA
concentrations varied from 0.5 ppb (0.6 lg/m3; night
maximum) to about 4 ppb (5 lg/m3; daytime maximum) in
a mixed hardwood forest at days with a wind direction
from areas with low anthropogenic pollution; FA was
mainly due to oxidation of isoprene (Galloway et al. 2012).
Absorption, distribution, metabolism and elimination
The summary is based on references in IARC (2006),
WHO (2010), Nielsen and Wolkoff (2010) and Wolkoff
and Nielsen (2010) except where otherwise stated. Thus,
due to the high water solubility and reactivity, airborne FA
is absorbed mainly in the upper airways ([90 %). Depo-
sition of reactive and water soluble gases was found to be
similar in the extrathoracic area of the airways of children
and adults (Ginsberg et al. 2010). In the water phase, FA
forms a water addition product, FA acetal [methylene
glycol, CH2(OH)2], which reacts with glutathione (GSH),
forming S-hydroxymethylglutathione (FA glutathione thi-
oacetal; HO–CH2–SG). This intermediate is oxidized by
the glutathione-dependent FA dehydrogenase [FDH, also
termed alcohol dehydrogenase 5 (ADH5) and previously
ADH3 (Just et al. 2011)] to S-formylglutathione and
hydrolyzed to GSH and formate (Andersen et al. 2010). FA
is an endogenous metabolite, for example, of serine, gly-
cine, methionine and choline. It is essential in the one-
carbon pool, which is involved in the biosynthesis of
nucleic acids and certain amino acids. Formate is incor-
porated in metabolic products or further oxidized to carbon
dioxide. Additionally, it is excreted in the urine (Hovda
et al. 2005; Soleimani 2001); due to the high background
formate excretion in the urine [from about 4 to C39 mg/day
(Berode et al. 2000)] no increase is expected due to inha-
lation of FA. Inhalation of FA does not increase the con-
centration of FA in the blood (about 2–3 mg/L). Rat studies
indicated that the half saturation of the nasal FA metabo-
lizing enzyme system is about 2.6 ppm (3.2 mg/m3).
Higher exposure levels cause a disproportionate increase in
nasal cellular levels of FA (Andersen et al. 2010). The half-
life of FA in blood is about 1–1 min. The mean exhaled
breath FA concentrations have been reported to be about
2 ppb (Ca´p et al. 2008; Fuchs et al. 2010) and the maxi-
mum about 12 ppb (Ca´p et al. 2008). FA is an electrophile,
which reacts with DNA, RNA and proteins forming
reversible adducts or irreversible cross-links. Thus, for-
mation of DNA–protein cross-links (DPX) in nasal tissue
in rats increased disproportionate at exposures above
2–3 ppm (2.5–3.6 mg/m3).
Several recent inhalation studies using labelled FA
(13CD2) did not find DNA adducts outside the nasal tissue
in rats and monkeys; thus, FA was not considered to reach
the internal organs or the blood compartment (Lu et al.
2010, 2011; Moeller et al. 2011; Swenberg et al. 2011).
This agrees with a dosimetry study that suggests
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intracellular FA concentrations in the nasal cells are only
marginally changed at exposures up to 2 ppm (Andersen
et al. 2010). Furthermore, gene expression studies showed
no change at 0.7 ppm (Andersen et al. 2008). In a 6-h
inhalation study in rats exposed to 10 ppm 13C-FA, no
inhaled FA was detected in the blood, neither during the
exposure nor after the exposure (Kleinnijenhuis 2012).
This should also apply to humans (Franks 2005). Overall,
these and previous studies support that FA acts as a portal-
of-entry toxicant if detoxification mechanisms are not
overwhelmed (WHO 2010; Nielsen and Wolkoff 2010).
However, a recent study considered biomonitoring of
airborne FA exposures from the terminal N-methylenvaline
residue in blood haemoglobin (Hgb). This unstable adduct
was reduced to the stable N-methylvaline adduct and
analysed after derivatization. Adduct formations were
compared with FA exposures (8-h sampling) in patholo-
gists, plastic laminate workers and low-exposed controls.
The mean FA concentration was 189, 210 and 41 lg/m3,
respectively, and the N-methylenvaline concentration 378,
343 and 145 nmol/g Hgb, respectively. Dividing exposures
into quartiles showed a significant exposure–response
relationship (Bono et al. 2012). For an evaluation, we
assume an 8-h working day (inhalation rate: 10 m3/8 h;
exposure concentration: 189 and 210 lg/m3, respectively)
and 16 h at the control level (inhalation rate: 20 m3/24 h;
exposure concentration: 41 lg/m3) in the non-occupational
exposure period, and 24 h exposure (inhalation rate:
20 m3/24 h; exposure concentration: 41 lg/m3) in the
controls. Thus, the inhaled FA dose during a 24-h day
would be 2,437, 2,647 and 820 lg/day, respectively. In
general, absorption of airborne FA into the blood is con-
sidered low. In humans, it was estimated that 1.9 ppm
increases blood FA at maximum by 15 lg/L during repe-
ated daily 8-h exposures (Franks 2005); the normal back-
ground blood FA level is about 2,000–3,000 lg/L. In rats
exposed 6 h/day for 5 days to 10 ppm FA, the exogenous
FA did not result in detectable FA–DNA adducts in blood
lymphocytes (Lu et al. 2010); this also indicated a low FA
absorption into the blood compartment. Furthermore, an
in vitro study showed that FA-exposed nasal epithelial cells
did not release FA subsequently (Neuss et al. 2010b); this
suggests that the nasal epithelium is an efficient barrier
between inhaled FA and the blood compartment. Never-
theless, we accept, as an upper boundary, that 1 % of the
inhaled dose may be delivered to the blood compartment,
which would be 24, 26 and 8 lg/day, respectively. Part of
the delivered dose would be metabolized in the blood
compartment, which is a fast process, and part of the
delivered dose would react with blood proteins, including
Hgb with valine as one of the binding sites. No accumu-
lation is considered to occur over long-term exposures due
to the fast metabolism of FA in blood and the reversible
nature of the reaction products (methylol derivatives) with
amino, hydroxyl and thiol groups in proteins; the primary
reaction product can undergo further (secondary) reactions.
The secondary reaction products may also be reversible, as
shown for DPX removal in human lymphocytes due to
spontaneous hydrolysis (Quievry and Zhitkovich 2000).
The total N-methylenvaline bound FA in Hgb can be
estimated to 8,514, 7,725 and 3,266 lg/person, accepting a
molecular mass of FA at 30.03, a Hgb concentration of
150 g/L blood and a blood volume of 5 L/person. Thus, the
delivered dose corresponds to 0.28, 0.34 and 0.24 %,
respectively, of the detected blood N-methylenvaline
amount. This calculation assumes no metabolism in the
blood compartment and furthermore, that the only binding
site in the blood compartment is the valine sites, which
clearly is an upper boundary assumption. However, even in
this case, can the inhaled FA only explain a marginal
amount of the measured N-methylenvaline adduct level.
Thus, it is difficult to corroborate that the inhaled FA
would be responsible for the observed differences in
N-methylenvaline adduct in Hgb. It is noted that in the
evaluation of the N-methylenvaline levels, neither high
peak exposures were investigated, which might overwhelm
the detoxification mechanisms, nor were potential differ-
ences in gender considered; among the pathologists, 42 %
were males, 100 % were males among the plastic laminate
workers and 29 % among the controls were males.
Non-carcinogenic airway effects
Odour and non-specific symptoms
A recent high-quality study determined the mean 50 % odour
detection threshold of FA to 110 ppb (0.135 mg/m3), but the
individual thresholds varied from 23 to 505 ppb (0.028–0.62
mg/m3) (Berglund et al. 2012). This further supports the
WHO’s (2010) conclusion that a significant fraction of the
population may perceive FA at or below 0.1 mg/m3.
A Japanese study comprised 5,709 randomly selected
households in dwellings (age B7 years); 2,297 returned a
preliminary questionnaire, and of these, 425 households
with 1,479 residents participated in the study. FA and 41
other volatile organic compounds (VOCs) were measured
in the dwellings (passive sampling for 24 h) and a ques-
tionnaire with sick-building syndrome (SBS) symptoms
(eye irritation, nasal, throat and lung, skin and general
symptoms as fatigue, heavy head, headache, nausea, diz-
ziness and difficulties in concentrating) were obtained from
the participants. FA and other aldehydes were the domi-
nating VOCs. Aldehydes and other VOCs were often sig-
nificantly higher in the SBS positive participants. The
positive participants comprised more females, younger
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participants, exposed to environmental tobacco smoke,
participants spending more time in their homes, reporting
mould growth and suffering from allergic diseases. Multi-
ple logistic regression analysis was used to calculate
adjusted odds ratios (ORs) in the quartiles of air concen-
trations. For the SBS positive participants, the ORs for FA
exposures were significantly increased in the second (OR:
2.1), third (OR: 2.3) and fourth quartiles (OR: 2.4; maxi-
mum FA: 203 lg/m3). In the fourth quartile, ORs were
significantly increased for n-nonane (OR: 2.4; maximum:
160 lg/m3), 1,2-dichloropropane (OR: 15; maximum:
3 lg/m3) and chlorodibromomethane (OR: 6; maxi-
mum: 6 lg/m3); the maximum concentration is the highest
measured concentration in all dwellings. OR for eye irri-
tation at FA exposure was 2.0, 4.2 and 1.7, respectively; the
value in the third quartile was statistically significant. ORs
for nasal irritation were 2.9, 2.6 and 1.7, respectively; the
first two values were significantly increased. It was con-
cluded that after adjustment for other possible risk factors,
FA dose dependence showed to be a significant risk factor
for SBS (Takigawa et al. 2010). Overall, the study was
conducted on a highly selected population and highly
increased ORs for SBS were observed at very low exposure
levels of some VOCs; this challenges a cause–effect rela-
tionship. It is apparent that the study shows no concentra-
tion-dependent effect of FA exposure. This weakens that
FA is causally related to the reported effects, except if they
are odour driven as the odour threshold may have been
exceeded. If FA at all is involved in the increased symptom
reporting, the odour of FA is not considered adverse below
0.1 mg/m3 (WHO 2010).
Sensory irritation
Perceived (sensory) irritation from the eyes and the upper
airways is considered the critical effect of acute effects of
FA. Formaldehyde activates the TRPA1 receptor (McNa-
mara et al. 2007) on the trigeminal nerves, which triggers
the sensation of sensory irritation (WHO 2010; Wolkoff
and Nielsen 2010). Sensory irritation sensitivity was not
related to genetic endpoints. This was observed in a study
with non-smoking male volunteers where nasal irritation
sensitivity to CO2 (a model sensory irritant) was compared
with FA dehydrogenase gene expression in leucocytes,
with in vitro FA-induced DPX formation and DPX removal
in leucocytes, and with FA-induced sister chromatide
exchange (SCE) in cultured lymphocytes (Zeller et al.
2011b).
A review of the sensory irritation studies indicated that
the most informative (key) study was a double-blinded 4-h
controlled chamber study by Lang et al. (2008). The con-
centration 0.5 ppm can be considered the lowest-observed-
adverse-effect level (LOAEL) where peaks of 1 ppm were
added or the no-observed-adverse-effect level (NOAEL)
without peaks. This was in reasonable agreement with
other chamber studies and with results from predictive
animal testing. Contrary, epidemiological studies have
reported associations, although not always consistent,
between symptoms and FA levels at more than 10 times
lower concentrations. These effects were from mixed
exposures where causative agents are not clear and con-
founders are likely present (Paustenbach et al. 1997; WHO
2010; Wolkoff and Nielsen 2010; Golden 2011); these
studies were disregarded in the WHO’s (2010) guideline
setting. Sensory irritation induced by FA is considered
concentration dependent and essentially not time depen-
dent after few hours of exposure (Paustenbach et al. 1997;
WHO 2010; Wolkoff and Nielsen 2010; Golden 2011).
Neither asthmatics (Paustenbach et al. 1997; WHO 2010;
Wolkoff and Nielsen 2010) nor children (WHO 2010;
Wolkoff and Nielsen 2010) were found to be at increased
risk. Thus, the NOAEL from the Lang et al.’s (2008) study
was used as the point of departure for setting the guideline
value. An assessment factor of five was used based on the
steepness of the exposure–response relationship and the
standard deviation of nasal pungency thresholds (WHO
2010; Wolkoff and Nielsen 2010), which after rounding led
to a guideline value of 0.1 mg/m3 (WHO 2010; Wolkoff
and Nielsen 2010). A nearly identical value [0.1 ppm
(0.12 mg/m3)] was derived in a recent review (Golden
2011).
Inter individual variations in FA-induced sensory irri-
tation were investigated in 4-h exposures in 41 males (aged
32 ± 10 years), where hypo- and hypersensitivity were
identified from CO2-induced nasal sensory irritation. The
FA concentrations were 0.5 and 0.7 ppm, 0.3 ppm with
four 15-min peaks at 0.6 ppm and 0.4 ppm with four
15-min peaks at 0.8 ppm. The FA exposures caused no
consistent effect on conjunctival redness, eye-blinking
frequency, self-reported tear film break-up time, mean
nasal flow rate, eye and nasal irritation intensity symptoms.
Furthermore, no difference between hypo- and hypersen-
sitive volunteers was observed. The FA exposures were
associated with increased olfactory triggered symptoms,
which increased in the hypersensitive subjects compared
with the hyposensitive subjects. NOAELs were 0.7 ppm at a
constant exposure and 0.4 ppm with peaks at 0.8 ppm, com-
prising both hypo- and hypersensitive individuals (Mueller
et al. 2012). Thus, this study is in overall agreement with the
Lang et al.’s (2008) study used in the guideline setting.
A prerequisite for the use of an acute study in the
guideline setting is that the FA-induced sensory irritation
effect does not increase upon daily repeated exposures.
This was addressed from repeated exposures of airborne
limonene–ozone reaction products in mice. In this mixture,
FA is responsible for a considerable part of the sensory
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irritating effect (Wolkoff et al. 2008). One-hour exposures
were conducted on 10 consecutive days. No increase was
observed in sensory irritation, airflow limitation and deep
lung effects at exposures from low to high sensory irrita-
tion levels (Wolkoff et al. 2012). This supports that the
sensory effects of FA can be established from acute
chamber studies in humans as is the case with the WHO’s
(2010) guideline. Also, the recent study by Mueller et al.
(2012) indicates that the WHO guideline is highly protec-
tive and takes into account the sensitive subjects.
Asthma
FA-dependent exposure–response relationships have not
been substantiated from lung function effects in controlled
chamber studies neither in healthy adults nor in asthmatics
below 1 mg/m3. Furthermore, associations between FA
exposures and exacerbation of asthma or sensitization have
not been convincingly demonstrated in children or adults at
exposures in homes or in schools (WHO 2010; Wolkoff
and Nielsen 2010). Similarly, a recent review concluded
that there was no clear association between FA concen-
trations in dwellings and development of childhood
asthma; consistent environmental risk factors were envi-
ronmental tobacco smoke, living close to busy roads and
living in damp homes with visible moulds (Heinrich 2011).
The association between FA exposures and asthma in
children was addressed in a recent meta-analysis (McGwin
et al. 2010). The fixed-effects model showed an OR of 1.03
(95 % CI 1.02–1.04) and the random effects model an OR
of 1.17 (1.01–1.36), both for an increment of 10 lg/m3 of
FA. The two most influential studies in the analyses were
the study of Rumchev et al. (2002) and the study by Garrett
et al. (1999).
The Rumchev et al.’s (2002) study is a case–control
study comprising 88 children (mean age: 25 months), who
were discharged from an emergency treatment for asthma,
and 104 non-asthmatic controls (mean age: 20 months). FA
was measured both in the winter and the summer period
and in the living rooms and the bedrooms of the children.
Children exposed to 60 lg/m3 FA had a 39 % increased
risk of asthma compared with children with\10 lg/m3 FA
in the air. The study acknowledged the difficulty of diag-
nosing asthma in the studied age group. Later on, an
entirely similar study was published by the same group. It
showed the presence of VOCs that were dominated by
benzene and toluene. Additionally, house-dust mites were
present in fine dust (Rumchev et al., 2004). The median
benzene and toluene concentration among the cases was 25
and 12 lg/m3, respectively, and among the controls, 12 and
6 lg/m3, respectively. Dust mite allergen levels were sig-
nificantly associated with total VOC levels. Benzene levels
of C20 lg/m3 were associated with an eightfold increase in
emergency treatment. As benzene and toluene are markers
of combustion products, it suggests that the FA exposure in
the first study is one component in a complex combustion
mixture. Due to the limitations, the Rumchev et al.’s
(2002) study has not been considered appropriate for
establishing exposure effects of FA (WHO 2010; Wolkoff
and Nielsen 2010; Golden 2011; NRC 2011).
In a cross-sectional study, Garrett et al. (1999) compared
53 asthmatic and 95 non-asthmatic children, aged
7–14 years. It was stated that ‘‘there was no significant
increase in adjusted risk of asthma or respiratory symptoms
with FA exposure’’. However, there was a marginal higher
geometric mean FA concentration (p = 0.06) in the bed-
room at the atopic children (19 lg/m3) compared with the
non-atopic children (16 lg/m3). This was significant
(p = 0.002) if the highest recorded FA concentrations from
the bedrooms, the living rooms, the kitchens and the out-
door levels were used, 38 vs. 29 lg/m3, respectively. The
OR (about 1.3–1.4) for atopy increased with an increase in
bedroom FA levels by 10 lg/m3. Results from an exactly
similar group of children showed that asthma was associ-
ated with exposure to Penicillium and atopy with exposure
to Aspergillus (Garrett et al. 1998). Overall, the use of
mixed exposure effects and lumping together unrelated
endpoints makes it difficult to interpret this meta-analysis
as previously pointed out (Golden 2011; Heinrich 2011).
A study was conducted in two cross-sectional-based
case-control populations with children, aged about
13 years, living in a French city (32 asthmatics and 31
controls) and its country side (24 asthmatics and 27 con-
trols). Asthma was identified by means of the questions:
‘‘has your child ever had asthma?’’, ‘‘has your child had
wheezing in the chest in the past 12 months?’’ or whether a
child has taken medication against an asthma crisis. The
controls answered ‘‘no’’ to the questions. Air pollutants,
including FA, were measured in the living room. Mea-
surements were carried out summer and winter in the urban
homes, but in the rural homes only in summer. The winter-
median FA concentration was 20.3 lg/m3 and the summer-
median concentration was 20.6 lg/m3 in the urban homes
and the summer-median concentration was 15.7 lg/m3 in
the rural homes. The FA exposure was marginally, but
significantly increased in the asthmatics [19.8 lg/m3
(range 5.8–75.1)] compared with the non-asthmatics
[17.2 lg/m3 (range 3.7–50.8)]. ORs were determined by
logistic models. In the combined population, the associa-
tion between FA and asthma was increased non-signifi-
cantly [OR (95 % CI) 1.7 (0.7–4.4)]. The increased OR
was driven by a significant increased OR (*11) in the rural
children, whereas the OR (*0.2–0.6) was non-significantly
decreased in the urban children (Hulin et al. 2010). As the
highest risk was observed in the lowest exposed FA group
(rural children), it is counterintuitive that the increase in
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ORs expresses a causal relationship. Also, cross-sectional
studies have a limited ability to establish causations.
In a study of 1,005 school children (aged 8–13 years) in
Korea, 12.8 % had self-reported asthma and 6.8 % physi-
cian-diagnosed asthma. A case–control study was con-
ducted with 33 asthmatic and 40 non-asthmatic children.
Personal exposures to FA and VOCs were obtained during
a 3-day period. No significant difference was observed
between FA and VOC exposures in the two groups; the geo-
metric mean FA concentration was 27 lg/m3 in the cases and
29 lg/m3 in the controls. Multiple logistic regression analysis
(adjusted for confounders) did not show any significant
difference between the children, suggesting other causative
factors for development of asthma (Hwang et al. 2011).
A cross-sectional study was conducted among 2,453
Korean school children, aged 10 years. Respiratory
symptoms were obtained by means of a questionnaire, and
indoor and outdoor exposures, including FA concentra-
tions, were measured. The mean FA concentration was
28 lg/m3 (range 16–47) in class rooms and the outdoor
level was 4.3 lg/m3 (range 2–9). There was no association
between class room FA exposures and wheeze, doctor
diagnosed asthma or current asthma, but wheeze was sig-
nificantly associated with reported indoor dampness and
mould growth in the home environments (Kim et al. 2011).
In a French cross-sectional study comprising 6,590
children with a mean age of 10 years from 401 randomly
selected classrooms, past-year rhinoconjunctivitis and past-
year asthma were obtained by means of a questionnaire.
Furthermore, exercise-induced asthma and skin prick test
reactions to 10 common allergens were investigated.
Classroom concentrations of fine particles (PM2,5) were
obtained by filter-based sampling, and NO2, FA, acetal-
dehyde and acrolein were obtained by passive sampling. A
significantly increased odds ratio (OR: 1.19) was observed
for past-year rhinoconjunctivitis at FA exposures exceed-
ing 28.4 lg/m3, but not for past-year asthma (OR: 0.90).
Furthermore, exercise-induced asthma was not correlated
with FA exposure. The authors concluded that school air
quality may affect rhinitis (FA) and asthma-related (PM2.5,
acrolein and NO2) morbidity. However, it was realized that
a cross-sectional study cannot provide causal relationships
(Annesi-Maesano et al. 2012)
Overall, recent field studies are about mixed exposures
where the effects of FA are indistinguishable from effects
of other components. None of the studies present a con-
vincing association between FA exposures and asthma, in
agreement with previous studies (WHO 2010).
Other airway or lung effects
In an Australian study, lung effects of low-NOx unflued
combustion products from gas heaters and gas heaters with
non-indoor-air emitting flue gas were compared in 4–6
grade school children (N = 400). The geometric mean
(95 % CI) concentration of NO2 in classroom was 31.6 ppb
(7.4–135.2) and 17.5 ppb (3.5–88.4), respectively, and of
FA 32.6 ppb (3.1–62.1) and 24.7 ppb (3.3–46.1), respec-
tively. However, when the heaters were used C30 % of the
day, the NO2 concentration was 2.33 times higher with the
unflued heater and the FA concentration was 20.1 ppb
higher compared with the flued heater. The only effect of
unflued heaters was minor, but statistically significant,
improvement in lung function at high-exposure days that
also applied to the subgroup of asthmatics. No adverse
symptom effect was observed in the non-atopics. Also, the
estimated effect of heater type on symptoms did not differ
significantly by current asthma status. However, the use of
unflued gas heaters was significantly associated with
evening cough (OR = 1.16) and morning wheeze (OR =
1.38); adjustment of the use of gas heating, open fire and
environmental tobacco smoke exposure at home increased
the OR for morning cough to 1.60. The values were no
longer significant if analyses were limited to days where
heaters were used C30 % of the day. In the subgroup
analyses with atopics, the use of unflued heaters was sig-
nificantly associated with a reduction in morning cough
(OR = 0.77) and an increase in morning wheeze (OR =
1.85), stomach ache (OR = 1.63) and use of bronchodila-
tors for relief of symptoms (OR = 1.87). If the analyses in
atopics were restricted to days where heaters were used
C30 %, increase in morning wheeze was significantly
increased (OR = 7.72) as was evening wheeze (OR =
3.97) (Marks et al. 2010). The study has a strong (double
blind, cluster randomized, crossover) design; it indicates
that gas combustion products were associated with
reported wheeze and cough mainly in the subgroup of
atopics. The study cannot disentangle which components
of the complex flue mixture are responsible for the asso-
ciations. However, if it is assumed that NO2 or FA are
causally related to the symptoms, they are most likely due
to deep lung effects of NO2 (WHO 2010) and not to FA,
which is mainly deposited in the upper airways (WHO
2010).
Children in a Paris birth cohort (N = 2,940) were
investigated for lower respiratory tract infections (LRIs)
and LRIs with wheeze (wLRIs) during first year of life
(Roda et al. 2011); the ‘‘never LRI’’ group was the refer-
ence group. Health data were obtained by questionnaires,
and building characteristics and lifestyle factors from
phone interviews. FA exposures were predicted for all
children from a model, which was derived from FA mea-
surements in about 200 randomly selected dwellings, their
building characteristics and the occupant activities. The
model classified 73 % of the dwellings correctly in the
group below and above the median, that is, 27 % could be
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misclassified and a random allocation is expected to clas-
sify 50 % correctly. The annual quartile ranges were
\14.4, 14.4–19.5, 19.5–26.8 and[26.8 lg/m3 FA and the
interquartile range from 14.2 to 26.8 lg/m3. In the inter-
quartile range, the association between symptoms and FA
exposures was significantly increased [OR (95 %): 1.32
(1.11–1.55)] for LRI and for wLRI [1.41 (1.14–1.74)] after
adjustment for risk factors. No OR was given for the upper
quartile range. However, the ORs were given for the upper
tertile range that was 1.31 (1.10–1.57) for LRI and 1.43
(1.14–1.79) for wLRI; no concentration was given for the
tertile ranges. Nevertheless, the upper tertile range includes
the upper quartile range and the upper part of the inter-
quartile range. As the ORs are identical at the interquartile
range and the upper tertile range, the associations between
FA exposures and LRIs and wLRIs were not exposure
dependent. This and the fact that much higher exposure
concentrations are not expected to reach the lower airways
in biologically significant concentrations cast doubt on a
potential cause–effect relationship. The authors mentioned
that ‘‘the duration of window opening reported by parents
was inversely associated with FA levels’’. A biologically
plausible explanation could be that the FA concentration is
a proxy for the ventilation in a dwelling where an increase
in FA concentration indicates an accumulation of all types
of indoor air pollutants of which some may be the causal
factor(s).
Overall, the two studies do not challenge the indoor air
guideline set by WHO (2010).
Genotoxicity
Different susceptibility to FA due to gene polymorphisms
has been addressed in several recent publications.
As FDH is the key enzyme in the FA metabolism, the
FDH gene polymorphisms were studied in blood cells.
Two polymorphisms reported in the literature did not show
polymorphic sequences in the studied population. In con-
trast, a third polymorphism (rs13832) showed a variable
allele in a group of 105 subjects. The differences did not
result in different FDH mRNA transcription between the
heterozygous and the homozygous groups. Also, the
in vitro DPX formation induced by FA was similar.
Overall, no relevant polymorphism in transcription of the
FDH gene was identified (Just et al. 2011).
FA-induced DPX formation and DPX removal were
studied in vitro in blood cultures from male smokers,
female non-smokers and children. The DPX formation was
slightly increased in children compared with the male
smokers, but not with the female non-smokers. The DPX
removal was slightly decreased compared with both adult
groups. However, the authors considered these small
differences to be biological insignificant. Additionally,
they may be explained by assay variability. FA-induced
DNA lesions were determined by SCE in cultivated lym-
phocytes, which showed no statistical difference between
the groups. The expression of FDH gene was not different
between children and the other two groups. Furthermore,
the FDH gene expression was neither correlated with DPX
nor with SCE formation. Blood glutathione S-transferase
(GST) M1 and GSTT1 genetic polymorphisms were not
related to DPX formation in FA-treated blood cultures
from all subjects, but a slightly higher induction of SCE
was found in cultures from subjects with homozygous
deletion of the GSTM1 (null) gene; this, however, was not
consistent with other studies. The authors concluded that
there was no biologically relevant difference in FA-
induced genetic susceptibility between the three groups
(Zeller et al. 2012).
Overall, no important gene polymorphism was identified
that caused increased susceptibility to FA. This is in
agreement with results from blood cell studies in
FA-exposed workers (see below).
Reaction with DNA in animal studies
Formaldehyde is genotoxic in multiple in vitro models and
in exposed humans and laboratory animals, including for-
mation of DPX, micronuclei (MN) (WHO 2010; Nielsen
and Wolkoff 2010), DNA monoadducts and DNA–DNA
cross-links (Swenberg et al. 2011). The DNA lesions
showed a nonlinear increase with increasing FA concen-
trations (WHO 2010; Nielsen and Wolkoff 2010; Lu et al.
2011; Swenberg et al. 2011). DNA lesions can result in
mutations if DNA replication takes place before they are
repaired (Swenberg et al. 2011). A major progress has
shown how to distinguish FA adducts generated from the
endogenous metabolism and adducts generated from
external exposures. External exposure of isotope labelled
FA (13CD2) can be distinguished from internal CH2O-FA
adducts by mass spectrometry (Lu et al. 2010, 2011, 2012;
Moeller et al. 2011; Swenberg et al. 2011).
Monoadducts [N2-hydroxymethyl-deoxyguanosine
(FA-dG) and N6-hydroxymethyl-deoxyadenosine (FA-dA)]
and DNA–DNA cross-links from deoxyguanosine-FA-
deoxyguanosine (dG-FA-dG) cross-links were present in
the rat nasal mucosa. Both exogenous and endogenous FA
caused FA-dG and dG-FA-dG formation, where the dG-
FA-dG adducts were about ten times lower than the FA-dG
adducts. Thus, the most sensitive adduct indicator was FA-
dG formation. Exogenous exposure did not induce FA-dA
formation, indicating that endogenous FA caused solely
additional DNA adducts compared with exogenous FA
exposure. The endogenous concentrations of FA adducts
were similar across the number of exposures, whereas the
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exogenous adducts increased with the number of exposures
(Table 1). Additionally, the three adducts were studied in
lung, liver, spleen, bone marrow, thymus and white blood
cells. The endogenous FA-dG adducts were in the range
from 1.1 to 3.2 adducts/107 dG nucleosides, the FA-dA
adducts from 1.9 to 4.0/107 dA nucleosides and dG-FA-dG
adducts from 0.09 to 0.21/107 dG nucleosides. However,
no exogenous adducts were detected. This shows that in
rats, no FA passes beyond the nasal mucosa even at a
10-ppm FA exposure. The marked increase in cell prolif-
eration in the nasal tissue induced by exposure to 10 and
15 ppm was considered to play a critical role in converting
both endogenous and exogenous labile promutagenic
adducts into mutations (Lu et al. 2010). After 6 h of
exposure to 10 ppm in rats, nearly half of the adducts was
lost during the first 6-h post-exposure due to cytotoxicity-
induced cell death and then followed by a decrease
corresponding to a half-life of about 94 h (Swenberg et al.
2011).
A single 6-h FA exposure in rats was used to investigate
exposure–response relationships for the FA-dG adducts
(Lu et al. 2011). The relationship was nonlinear; at low
exposures, the endogenous FA adducts dominated. The
exogenous adduct level followed a relationship similar to
the development of squamous cell carcinoma in a 2-year rat
study (Table 2). Furthermore, external FA-dG adducts
were not detected in the bone marrow. Adducts after
inhalation of FA in monkeys can be compared with adducts
in rats (Table 2). The number of exogenous adducts after
one exposure in rats and two exposures in monkeys was
similar at 2 ppm, but about 2.5-fold lower in primates at
6 ppm. This suggests that the nasal cancer risk from FA
exposures may be lower in primates. Also in the primates,
no exogenous FA adduct was detected in the bone marrow.
Table 1 Number of monoadducts [N2-hydroxymethyl-deoxyguano-
sine (FA-dG) and N6-hydroxymethyl-deoxyadenosine (FA-dA)] and
DNA–DNA cross-links from deoxyguanosine-FA-deoxyguanosine
(dG-FA-dG) cross-links per 107 dG, dA and dG nucleosides,
respectively, were studied in the male Fischer 344 rat nasal mucosa
Number of days Concentration (ppm) FA-dG FA-dG FA-dA dG-FA-dG dG-FA-dG
Exogenous Endogenous Endogenous Exogenous Endogenous
1 10 1.3a 2.6a 4.0a,b 0.14a 0.17a
5 10 2.4 2.8 3.6b) 0.26 0.18
FA exposures were for 6 h/day for 1 or 5 days (Lu et al. 2010)
a The coefficient of variation was between 7 and 43 % across all adducts and all exposures
b Exogenous adduct was not detected in the nasal mucosa
Table 2 The monoadducts N2-hydroxymethyl-deoxyguanosine (FA-dG) was used as a biomarker of FA-induced DNA adducts in rat nasal











Rats 6 h 0.7 3.6a 0.04b 0.01c 0/90 (0)
6 h 2 6.1 0.19 0.03 0/96 (0)
6 h 6 5.5 1.0 0.2 1/90 (1.1)
6 h 9/10d 3.4 2.0 0.6 20/90 (22)
6 h 15 4.2 11.2 2.8 69/147 (47)
Monkeys 6 h, 2 days 2 2.5e 0.26f 0.10g –
6 h, 2 days 6 2.1 0.41 0.20g –
The nasal epithelial squamous cell carcinoma (SCC) frequency in male rats was from a 2-year inhalation study (Monticello et al. 1996)
a The coefficient of variation was in the range 13–50 % for all exposure concentrations
b The coefficient of variation was in the range 21–49 % for all exposure concentrations
c Since the endogenous FA-dG did not vary in an exposure-dependent manner, the ratio was calculated from the endogenous and the exogenous
adducts in each rat
d Exposures in the FA-dG group was 9 ppm and in the 2-year study 10 ppm
e The coefficient of variation was in the range 16–26 % for all exposure concentrations
f The coefficient of variation was in the range 12–15 % for all exposure concentrations
g Ratio from the endogenous and the exogenous columns; exposures for 2 days causes a higher exogenous accumulation than exposures for
1 day
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As in rats, this suggests that inhaled FA does not reach the
bone marrow (Moeller et al. 2011).
Overall, the recent molecular dosimetry studies seri-
ously question the biological plausibility of the epidemio-
logical studies, suggesting that inhaled FA causes
leukaemia and Hodgkin lymphoma (Swenberg et al. 2011).
Point mutations in rat nasal tissue
It was not clear whether FA-induced gene mutations are the
key events in FA-induced nasal carcinogenesis. As genetic
lesions on oncogenes or tumour suppressor genes are the
key events in carcinogenesis in general, the rat p53 codon
271 CGT to CAT and the K-Ras codon 12 GGT to GAT
mutations were studied as hotspot cancer inducing muta-
tions and because these mutations had been observed in
nasal tumours from FA-exposed rats. Rats were exposed to
0, 0.7, 2, 6, 10 and 15 ppm FA for 6 h/day, 5 days/week for
13 weeks as epithelial changes are known to occur within
1 week of FA exposures. No exposure-dependent increase
was observed in p53 mutations and no K-Ras mutation was
detected at all despite a strong exposure-dependent
increase occurred in cell proliferation at the higher con-
centrations. These point mutations have the strongest
association with FA-induced nasal tumours in rats, sug-
gesting that FA is not carcinogenic through a point muta-
tion mode-of-action and that the observed mutations occur
after key events like formation of DPX, cytotoxicity, cell
proliferation, and pre-neoplastic lesions (Meng et al. 2010).
Overall, this study did not find point mutations from FA
exposure in rats and thus does not indicate a linear
extrapolation for risk assessment.
Gene expression in rat nasal tissue
A microarray study was conducted with FA exposures at 0,
0.7, 2 and 6 ppm for 6 h/day, 5 days/week for up to
3 weeks in rats. Additionally, a single 6-h exposure to
15 ppm was included. No increase was observed in cell
proliferation, histopathology and change in gene expres-
sion in rat nasal tissue at 0.7 ppm FA. At 2 ppm, cell
proliferation was non-significantly increased and histopa-
thology showed minimal inflammatory infiltration and
epithelial hyperplasia; the maximum was within the first
5 days. On day 5, 15 genes had changed expression, but no
gene expression was changed significantly at day 15,
indicating tissue adaptation and reduced tissue sensitivity.
At 6 ppm, cell proliferation was increased significantly,
histopathological changes, including squamous metaplasia,
were increased and major changes occurred in gene
expression. Benchmark dose (BMD) analyses were per-
formed on the day 1 gene expression, which showed the
lowest BMD (1.60 ppm) for the gene expression related to
the basal plasma membrane. FA at 2 ppm primarily
affected the extracellular matrix or external plasma mem-
brane proteins of the epithelium (Andersen et al. 2008).
The above-mentioned microarray study was extended
(Andersen et al. 2010). Rats were exposed to 0, 0.7, 2, 6, 10
and 15 ppm 6 h/day for 1, 4 or 13 weeks. The nasal tissue
was analysed by histopathology and for cell proliferation.
Nasal tissue gene expression was studied at all concentra-
tions, but gene set enrichment analysis [groups of genes
that share common biological function, chromosomal
location or regulation (Subramanian et al. 2005)] was
limited to the three highest FA concentrations. The
developed pharmacokinetic model took the endogenous FA
level into account. At low dose external FA exposures, the
tissue CH2(OH)2 showed a plateau. Exposures at 0.7 ppm
FA had little effect on the tissue concentration of
CH2(OH)2 and GSH, and 2 ppm caused only a minimal
change in cellular GSH and CH2(OH)2. Exposure to several
ppm FA was needed before the predicted levels would
change significantly. A steeper increase in CH2(OH)2 and a
more pronounced decrease in GSH occurred above 4 ppm.
Treatment-related nasal lesions were found at exposure
C2 ppm FA. Cell proliferation was not increased at 0.7 and
2 ppm, but increased at higher FA concentrations. At
13 weeks of exposure at C6 ppm, the most significant
enriched pathways were related to cell cycle and DNA
damage. Seven genes upregulated at 2 ppm after 1 week of
exposure in the previous study (Andersen et al. 2008) and
upregulated at 6 ppm in this study were combined in a
group comprising ‘‘sensitive response genes’’ and analyzed
by the BMD method. For all three exposure durations, this
group had the lowest BMD (C1 ppm) of upregulated
genes. Presumably, they represent responses to extracel-
lular irritancy, reduction in extracellular membrane anti-
oxidant thiols, responses to maintain reduced extracellular
thiols and export of GSH to the extracellular space. The
BMDs for cell-cycle control and DNA repair were in the
3–5 ppm range. It was concluded that (1) exposure–
response relationships were nonlinear, (2) a threshold
exists and (3) that ‘‘FA concentrations below 1 or 2 ppm
would not increase risk of cancer in the nose or any other
tissue or affect FA homeostasis within epithelial cells’’.
Genotoxicity in human nasal and buccal mucosa cells
Several studies have been conducted on the frequency of
MN in the nasal and buccal mucosa cells in relation to FA
exposures in humans (Speit and Schmid 2006; Nielsen and
Wolkoff 2010; Knasmueller et al. 2011). Further, 21 vol-
unteers were exposed up to 0.5 ppm with four 15-min
peaks at 1 ppm, respectively; exposures were for 4 h/day
over a period of 10 working days. Buccal cells did not
show a statistically significant increase in MN (Speit et al.
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2007). Overall, this was in agreement with the conclusion
that if FA induced such an effect, it would be limited to
high mean or high peak exposures (Nielsen and Wolkoff
2010).
In a Portuguese study, 50 employees from pathology and
anatomy laboratories and 30 workers from a FA and FA-
based resin production factory were investigated for
induction of MN in exfoliated epithelial cells from the
buccal mucosa; 85 non-exposed were the controls. The
buccal cell MN frequency was significantly increased in
factory workers (mean ± SD: 1.3 ± 1.6) and in those from
the laboratories (0.6 ± 1.7) compared with the frequency
in the controls (0.1 ± 0.5). Student’s t test was used for the
analyses, but it is apparent from the SDs that the distri-
butions are skewed. This indicates that the statistical out-
come should to be taken cautiously. The MN frequency in
buccal cells was significantly, but weakly correlated
(r2 = 0.04) with the years of exposure. Mean FA exposure
in the factory was 0.21 ppm (range 0.20–0.22) and the
mean ceiling concentration was 0.52 ppm (0.003–1.04);
since both values were based on only two samples, the data
from the factory population cannot be considered robust.
However, it was also reported that ceiling values at reactor
sample collection and impregnation machine operation
exceeded 1 ppm FA. The mean exposure in the laboratory
employees was 0.28 ppm (0.05–0.51), based on 29 sam-
ples, and the mean ceiling concentration 2.52 ppm
(0.02–5.02); the highest exposure was at macroscopic
examinations by pathologists (Viegas et al. 2010). It is
noted that both groups had exposures exceeding 1 ppm FA.
Furthermore, the apparently lowest FA-exposed factory
workers had the highest frequency of MN, which suggests
that the exposures among the factory workers have been
greatly underestimated, if the MN formation is driven by
FA exposure.
In another Portuguese report, buccal cells were studied
for MN formation in 56 employees exposed to FA in
pathological laboratories and 85 non-exposed controls. The
mean FA concentration was 0.16 ppm (0.04–0.51) and the
mean ceiling concentration was 1.14 ppm (0.18–2.93).
The MN in the buccal cells was significantly higher among
the exposed (0.96 ± 0.28) compared with the controls
(0.16 ± 0.06) (Ladeira et al. 2011). It is noted that the
control groups in the Viegas et al. (2010) and the Ladeira
et al. (2011) studies have the same number of males and
females, have the same age distribution and the same dis-
tribution of smokers and non-smokers; this may indicates
that the two studies were not independent.
In a controlled chamber study, non-smoking males were
exposed 4 h/day for 5 consecutive days to FA. The FA
concentrations were 0, 0.3 (with four 15-min peaks at
0.6 ppm), 0.4 (with four 15-min peaks at 0.8 ppm), 0.5 and
0.7 ppm. Induction of MN formation was studied in nasal
epithelial cells up to 3 weeks post-exposure. Full-genome
DNA microarray analyses were performed on nasal biop-
sies. The FA concentrations did not increase MN formation
or cause change of expression of genes in the mucosa cells
(Zeller et al. 2011a), consistent with a study in rats
(Andersen et al. 2010).
The genomic results from the rat studies were supported
from in vitro studies in human nasal epithelial cells (Neuss
et al. 2010a). Thus, increased gene expression was expo-
sure dependent with a no-effect-level (NOEL). Addition-
ally, genes involved in FA detoxification showed no
change in expression. Up regulation of genes at high FA
exposures were similar to the up regulations seen in an
inhalation study in rats (Andersen et al. 2008).
Overall, in both studies in pathology laboratory
employees, MN formation in buccal cells was associated
with high FA peak exposures, which agrees with the pre-
vious evaluation (Nielsen and Wolkoff 2010). Furthermore,
if a low mean exposure concentration is due to series of
high peak exposures, the mean level is not a representative
of a mean indoor air level of FA as the indoor air FA levels
are roughly constant. Therefore, mean exposure concen-
trations due to series of high peak exposures cannot be used
for setting an indoor air guideline.
Chromosomal effects in peripheral blood lymphocytes
Human biomonitoring studies have shown increased DPX
formation, SCE and MN formation in blood cell cultures.
However, the human studies showed no robust exposure–
response relationship. The studies included mean and peak
exposure concentrations at C1 ppm. It was concluded that
high FA levels caused the effects and overwhelmed the
epithelial detoxification mechanisms, if the effects were
due to FA exposures. Therefore, it was concluded that the
mean and the peak concentrations have to be below 1 ppm
at a set guideline. As 1 ppm is the NOAEL for histopa-
thological effects in rats, risk characterization based on the
nasal effects in rats was considered to protect against
chromosomal effects in peripheral lymphocytes in humans
(Nielsen and Wolkoff 2010). The National Research
Council (NRC) recently acknowledged that inhaled FA has
a cytogenetic effect in peripheral blood cells, but it is not
possible to conclude that FA causes cytogenetic effects at
distant sites and extrapolation to typical environmental
exposures is difficult. It was hypothesized that the observed
effect was from an unproven mechanism in portal-of-entry
tissues (NRC 2011). Newer studies are listed in Table 3.
In a Hungarian study in pathology departments, 37
women exposed for 4–34 years to FA and 37 non-exposed
controls were compared; 16 of the FA exposed were also
exposed to solvents, whereas 21 were mainly exposed to
FA. In the FA exposed, ex vivo cultivated lymphocytes
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showed approximately doubling of apoptosis and chro-
mosomal aberrations (CAs), which were mostly breaks of
the chromatid type; both effects were statistically signifi-
cant. In the group mainly exposed to FA, the half of the
employees with the longest exposure (mean employment:
26 years; N = 10) had a CA frequency of 1.7 %, whereas
the half with the shortest exposure (mean employment:
10 years; N = 11) had a frequency of 4.4 % that was
significantly different. SCE- and UV-induced DNA-repair
synthesis was similar among exposed and controls.
Aneuploidy was significantly lower (approximately halved)
in both FA groups compared with the controls. HPRT gene
mutations were similar in controls and the FA plus solvent
group, but significantly reduced in the FA mainly group.
FA exposures were measured at fixed locations and thus,
personal exposures may have been higher. The 8-h time-
weighted average (TWA) was 0.9 mg/m3 (range
0.23–1.21 mg/m3) [0.7 (0.2–1.0) ppm)]. High-exposure
levels were confirmed from all employees reporting eye
symptoms (Jakab et al. 2010). If exposures are part of the
Table 3 Cytogenetic effects in peripheral blood lymphocytes in formaldehyde (FA)-exposed individuals
Exposure Number of participants; exposed
(E), controls (C) and smokers (S)
Exposure in years,
mean (range) or as
indicated
Exposure in ppm
Mean (M) (range) or
indicated






(Jakab et al. 2010)
E (FA ? Solvents): 16 (S: 6) 22 (7–34) Both FA-exposed groups:












C (unexposed): 37 (S: 6) Non-exposed
Plywood industry
workers (Jiang et al.
2010)























C: 85 (S: 25)
Pathology/anatomy
laboratories





S: 25 in the combined groups
(N = 80)
6.2 (1–27) M: 0.21 (0.20–0.22) (8 h
TWA)
P: 0.52 (0.003–1.04)
Both are from 2 samples
MN: not significantly
increased
FA and FA-based resins
production
(Viegas et al. 2010)
C: 85 (S: 26)
Pathology departments
(Santovito et al. 2011)
E: 20 (S: 0) 13 (2–27) M: 0.059 (SD: 0.010) (8 h
TWA)
CA: increased
C: 16 (S: 0) M: 0.030 (SD: 0.005) (8 h
TWA)
CA chromosomal aberrations, Comet comet assay and pos positive for genotoxicity , HPRT HPRT mutations, MN micronucleus, NBUD nuclear buds,
NPB nucleoplasmic bridges, SCE sister-chromatid exchange, TWA time-weighted average exposure, UDS UV-induced unscheduled DNA repair
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working day, task-specific exposures are higher. Also, peak
exposures are higher than the mean concentrations.
In a Chinese study, 151 FA-exposed plywood industry
workers were compared with 112 non-exposed controls from
a machine manufactory. FA was determined as the 8-h time-
weighted average concentration by personal sampling. The
mean FA concentration was 0.83 ppm (range 0.08–6.3) in
the exposed and below 0.008 ppm in the controls. Geno-
toxicity was studied in isolated lymphocytes by means of the
comet assay and results presented as the olive tail moment
(TM). The TM increased in a concentration-dependent
manner and was significantly increased at C0.11 ppm FA
compared with the controls. However, there was no expo-
sure-dependent effect in the range 0.11–0.39 ppm. Also,
genotoxicity was studied in the cytokinesis-block micronu-
cleus assay (CBMN) in cultivated lymphocytes. The CBMN
frequency increased in a concentration-dependent manner
and the frequency was significantly increased at 0.28 ppm.
None of the biomarkers were affected by age, current
smoking or alcohol consumption. GST polymorphisms
(GSTM1, GSTT1 and GSTP1) were not significantly asso-
ciated with TM or CBMN frequency, although the GSTM1
null genotype had a slightly higher TM than the GSTM1 non-
null genotype (3.86 vs. 3.27, p = 0.07), and GSTP1 (Ile/
Val ? Val/Val) were borderline increased compared with
the GSTP1 (Ile/Ile) genotype (6.32 vs. 5.01, p = 0.05) in the
CBMN test (Jiang et al. 2010).
In a Portuguese study, 48 FA-exposed employees in
pathology and anatomy laboratories were compared with
50 non-exposed controls. Lymphocyte cultures in the FA
exposed showed increased MN formation and blood lym-
phocytes had increased DNA damage identified by the
comet assay. The 8-h mean TWA concentration was 0.43
(range 0.04–1.6) ppm (Costa et al. 2011), also suggesting
that high peak exposures were present.
In an another Portuguese study by Viegas et al. (2010),
which was discussed in relation to effects in buccal cells,
workers from a FA and FA-based resin production factory and
employees from pathology and anatomy laboratories were
also investigated for induction of MN in peripheral blood
lymphocyte cultures; for further discussion and limitations of
the study, see the discussion in relation to buccal cells. The
MN frequency in the blood lymphocytes was non-signifi-
cantly increased in the factory workers (mean ± SD:
1.8 ± 2.1) and significantly increased in the laboratory
employees (3.7 ± 3.9) in comparison with the controls
(1.2 ± 2.0). The MN frequency in blood lymphocytes
increased significantly (r2 = 0.16) with years of exposure.
Mean FA exposure in the factory was 0.21 ppm (range
0.20–0.22) and the mean peak exposure was 0.52 ppm
(0.003–1.04), both were based only on two samples and thus
not robust for establishing exposure–response relationships.
The mean exposure in the laboratory employees was
0.28 ppm (0.05–0.51), based on 29 samples, and the mean
peak (ceiling) concentration was 2.52 ppm (0.02–5.02).
In a third study in Portugal, peripheral lymphocytes were
studied in 56 employees exposed to FA in pathological lab-
oratories and 85 non-exposed controls by means of the cyto-
kinesis-block MN test, comprising MN formation (biomarker
of chromosomal breakage or loss), nucleoplasmic bridges
(NPB; biomarkers of chromosome rearrangement, poor repair
and/or telomere fusion) and nuclear buds (NBUD; biomarker
of elimination of amplified DNA). The mean exposure con-
centration was 0.16 ppm (0.04–0.51) and the mean peak
concentration 1.14 ppm (0.18–2.93). Compared with the
controls, the FA-exposed employees had significantly higher
occurrence of MN (4.0 ± 0.53 vs. 0.81 ± 0.17), NPB
(3.0 ± 0.52 vs. 0.18 ± 0.06) and NBUD (0.98 ± 0.27 vs.
0.07 ± 0.3) (Ladeira et al. 2011). The MN frequency from the
study was re-evaluated blindly by two trained and experienced
scorers (2 and 3). In the original study, all slides were scored
by the first author (scorer 1). Scorer 2 evaluated 32 exposed
and 36 non-exposed participants and the MN frequency from
1,000 binucleated cells per participant was 9.9 and 6.8,
respectively; the difference was not significant (p = 0.17).
Scorer 3 evaluated 20 exposed and 46 non-exposed partici-
pants and the frequency was 19 and 13, respectively,
p = 0.09. However, the combined results from scorer 2 and 3
was 13.4 and 10.2, respectively, which was significant
(p = 0.03) and thus supported that there was a difference
between exposed and non-exposed as found by scorer 1.
Nevertheless, there were conspicuous differences between the
absolute frequencies from the different scorers. Furthermore,
when slides were evaluated twice by each scorer, the results
were highly variable. Overall, it was concluded that the
reproducibility was poor and reliability of the MN frequencies
was limited (Speit et al. 2012).
In an Italian study, 20 pathology workers (30 % males)
were compared with 16 hospital workers (44 % males).
None of the participants smoked, consumed alcohol or
drugs for a period of at least 1 year prior to the study. The
mean (±SD) 8-h time-weighted average FA concentration
was 73 ± 57 lg/m3 (0.059 ± 0.010 ppm) and 36 ± 6.8
lg/m3 (0.030 ± 0.005 ppm), respectively. Blood cells
were cultivated 48 h and scored for CAs in 100 metaphases
per subject; CAs were defined as chromatid breaks, chro-
mosome breaks, dicentrics and chromatid exchange. The
mean CA frequency per cell was significantly increased in
pathologists compared with the controls (0.03 vs. 0.01).
The different GST phenotype polymorphisms (GSTT
positive, GSTT null, GSTM positive and GSTM null) were
not associated with CA frequencies (Santovito et al. 2011).
It is noted that peak exposures were not measured and no
other chemical confounders were included in the study.
Effects of FA at distant to the portal-of-entry site have
been proposed; FA may be transported to internal organs
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where it acts or FA may affect cells in the blood. Furthermore,
effect may be on cells passing through the nasal tissue or
residing in the nasal tissue (Zhang et al. 2010a). The two first
mechanisms are unlikely based on toxicokinetics of FA. As
lymphocytes pass through the nasal tissue, FA effects were
studied in an in vitro assay. Human nasal epithelial cells were
exposed in vitro to high concentrations of FA, which caused
DPX formation. After change of the exposure medium, cells
were co-cultivated with human lymphocytes. No DPX for-
mation was observed in the lymphocytes and no biological
relevant amount of FA was released to the new medium. It was
therefore considered unlikely that inhaled FA could cause
genotoxic effects in blood cells as FA was not considered to
pass through the epithelial barrier and reach the blood com-
partment (Neuss et al. 2010b). Overall, this study did not sup-
port the last of the three hypotheses by Zhang et al. (2010a).
In highly exposed (mean: 2.1 ppm and 90 percentile:
4.1 ppm FA) Chinese workers, blood progenitor cells of the
myeloid line were derived by cultivation of blood cells. The
cultivated progenitor cells showed increased loss (mono-
somy) of chromosome 7 and increase (trisomy) of chromo-
some 8 compared with 12 non-exposed workers (Zhang et al.
2010b); limitations in context of risk characterization have
been discussed (WHO 2010; Nielsen and Wolkoff 2010;
Rhomberg et al. 2011). Furthermore, a recent study did not
find aneuploid effect of FA in vitro by exposure of human
progenitor cells; in contrast to vincristine, a known aneugen.
The authors concluded that it is unlikely that the aneuploidy in
the Zhang et al. study could be caused by FA exposure (Ku-
ehner et al. 2012).
In a controlled chamber study with non-smoking males, FA
exposures were 4 h/day for 5 consecutive days. The FA con-
centrations were 0, 0.3 (with 4, 15-min peaks at 0.6 ppm), 0.4
(with 4, 15-min peaks at 0.8 ppm), 0.5 and 0.7 ppm. In vivo
blood genotoxicity was evaluated by the comet assay, and from
induction of SCE and MN in cultured lymphocytes. FA
dehydrogenase expression was studied in blood cells. Full-
genome DNA microarray analyses were performed on blood
samples. The FA concentrations did not cause genotoxic effects
in peripheral blood cells and had no effect on FA dehydroge-
nase gene expression. Additionally, human blood cells were
stimulated in vitro for 4 h with up to 200 lM FA (6 mg/L) and
studied for gene expression. The FA stimulation increased gene
expression at 200 lM, but not at B100 lM (3 mg/L) (Zeller
et al. 2011a); the normal blood FA level is 2–3 mg/L.
Overall, the controlled chamber study showed no
genotoxicity in white blood cells up to 0.7 ppm FA. In the
epidemiological studies where genotoxicity was observed,
mean peak FA concentrations occasionally exceeded
1 ppm and peak concentrations were considerably above
this level. This is in agreement with the earlier conclusion
that a guideline value has to be below 1 ppm both for the
mean and peak concentrations (Nielsen and Wolkoff 2010).
Portal-of-entry carcinogenicity
Nasal cancer in rats
Nasal squamous cell carcinoma in rats was considered the
critical cancer effect due to FA exposure and together with
the mode-of-action and it constituted the basis for the
cancer risk assessment of indoor air exposures (WHO
2010). For development of SCC, Fischer 344 and Sprague–
Dawley rats were more sensitive than Wistar rats. Rats
were more sensitive than mice and Syrian golden hamsters.
The results from four long-term studies with sensitive rat
strains are combined in Table 4, showing the frequency of
SCC among exposed rats. Apparently, the concentration–
response relationship is nonlinear with an NOAEL for SCC
at 2 ppm (Nielsen and Wolkoff 2010).
DPX levels in nasal tissue have been used as a marker of
FA-induced DNA damage. At similar FA concentrations,
the DPX level was higher in rats compared with monkeys
(a proxy for humans), which suggests that rats is a sensitive
species (Nielsen and Wolkoff 2010). Similar results have
recently been seen from FA–DNA adducts (Moeller et al.
2011; Swenberg et al. 2011). This indicates that no
assessment factor is needed for extrapolation from rats to
humans (Nielsen and Wolkoff 2010).
In the development of SCC, cytolethality-regenerative
cell proliferation plays a key role. Increase in cell prolif-
eration was observed at C2 ppm FA. No histopathological
effect was observed at continuous exposure to B1 ppm FA
in the nose (WHO 2010; Nielsen and Wolkoff 2010),
Table 4 Nasal epithelial squamous cell carcinomas (SCC) in com-
bined groups of male and female rats from four long-term inhalation
studies with formaldehyde (FA) exposures









In the four studies, all exposures were for 6 h/day, 5 days/week.
Kerns et al. (1983) exposed Fischer rats for 24 months which was
followed by 6 months of non-exposure; FA exposures: 0, 2, 6 and
14 ppm. Groups contained from 117–119 males and 114–118
females. Sellakumar et al. (1985) exposed male Sprague–Dawley rats,
99–100/group, lifelong; FA exposures: were 0 and 15. Monticello
et al. (1996) exposed male Fischer 344 rats, 90–147 per group, for
24 months; FA exposures: 0, 0.7, 2, 6, 10 and 15 ppm. Kamata et al.
(1997) exposed male Fischer 344 rats, 32/exposure level, for up to
28 months; FA exposures: 0, 0.3, 2 and 15 ppm
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considered to be the NOAEL for cytotoxicity. This value
was used as the point of departure for evaluation of FA-
induced nasal cancer (WHO 2010; Nielsen and Wolkoff
2010). Also, it should be noted that there is no indica-
tion that points to a linear exposure–response relationship
(Table 4). Furthermore, a nonlinear exposure–response rela-
tionship is indicated from the recent toxicokinetic studies,
which showed that the FA–DNA products are driven by
endogenous formed FA at low airborne exposures.
Nasal cancer in humans
That FA may cause nasopharyngeal cancer (NPC) in
humans was based on a non-significant increase in the
standardized mortality ratio [SMR (exact 95 % CI): 2.10
(0.91–4.14)] in the US National Cancer Institute (NCI)
cohort comprising 25,619 workers employed in 10 US FA
producing or using facilities; workers were employed prior
to 1 January 1966 and were followed-up through 31
December 1994 (Hauptmann et al. 2004). Four metrics
(average exposure, highest peak exposure, cumulative
exposure and duration of exposure) were used for the study
of exposure–response relationships. Relative risks (RR)
were obtained with unexposed as the reference group. The
average exposure intensities were divided into groups: [0
to \0.5, 0.5 to \1 and [1 ppm where RRs were not
obtainable (0/3,640 deaths), 0.38 (1/1,405) and 1.67
(6/1,450), respectively. As observed in the rat studies, the
trend was nonlinear and an NOAEL was established from
the exposure–response relationships; the increased risk was
at C1 ppm. However, the trend was not significant. In the
peak exposure group, all deaths in the FA groups were in
the highest exposure group (C4 ppm), and the trend was
significant. An exposure-dependent trend was found in the
cumulative exposure groups, which was appeared to be
driven by the highest exposure level.
The study has several limitations (WHO 2010; Nielsen and
Wolkoff 2010; Golden 2011); the majority of FA cases were in
one of the plants [SMR (95 %CI): 10 (4–22)] and with a low
risk in the other nine plants [0.65 (0.08–2.33)]. Most cases in
the high-risk plant had short exposures and confounder
exposures from previous occupations. Also, the study missed
1006 deaths from the cohort, which may have influenced the
risk estimates (Marsh et al. 2010). The two other major
occupational cohorts (Coggon et al. 2003; Pinkerton et al.
2004) evaluated by the WHO (2010) had no excess in naso-
pharyngeal cancer. Additionally, the NCI case–control study
on lymphohematopoietic malignancies in FA exposed in the
funeral industry showed no excess in NPC [OR (95 % CI): 0.1
(0.01–1.2)] (Hauptmann et al. 2009).
Ignoring the limitations of the study, it was accepted by the
WHO (2010) that a mean exposure level has to be below
1 ppm and the peak exposures were below 4 ppm for
guideline setting. As the rat nasal histopathological effect and
the nasal cell proliferation had an NOAEL at 1 ppm FA, it was
accepted that a risk assessment based on nasal histopathology
in rats would protects against NPC in humans (WHO 2010).
Also at present, this stands as a sound conclusion.
Other portal-of-entry cancers
A recent meta-analysis, comprising six case–control stud-
ies and five cohort studies, found no association between
FA exposure and laryngeal cancer [meta relative risk (mRR
(95 % CI): 1.13 (0.98–1.31)] (Paget-Bailly et al. 2012).
The association between FA exposure and the incidence of
lung cancer was investigated in a case–cohort study nested
within a cohort of 267,400 female textile workers in Shanghai.
From the period 1989–1998, the incident lung cancer cases
(N = 628) were compared with a randomly selected subco-
hort (N = 3,185) from the entire cohort. Exposures were from
a job-exposure matrix for textile factories with dichotomous
(exposed vs. non-exposed) classification. The relative risk
[hazard ratio, HR (95 % CI)] was adjusted for age and
smoking. Two cases among the 628 cases had a FA exposure
of C10 years of exposure whereas five among the 3,185 non-
cases had a FA exposure of C10 years, with a HR of 2.1
(0.4–11). It was noted that the non-significant result is based
on a small number of cases and non-cases (Checkoway et al.
2011), but the result agrees with the view that only a small
fraction of inhaled FA reaches the lungs and FA is not found to
cause lung cancer (WHO 2010).
An ecological study merged emission to the environ-
ment (air, land, surface water, sewage treatment plants, off-
site locations for recycling and waste disposal) in the USA
from the Toxics Release Inventory Database and the lung
cancer incidence and survival from the Surveillance, Epi-
demiology and End Results Programme. After adjustment
for confounders, a statistically significant association was
observed between FA release and lung cancer at the county
level, which was also found for chromium and nickel.
However, after stratification into metro and non-metro coun-
ties, the association was only significant for non-metro
counties (Luo et al. 2011). The study has several limitations
that include lack of personal exposure data on FA and con-
founders (e.g. smoking and occupational exposures) and lack
of concordance between metro and non-metro counties; thus,
it cannot be used for evaluation of FA effects.
Lymphohematopoietic malignancies
Animal studies
In three drinking-water studies with 2-year FA exposure in
rats, two well-conducted studies showed no increase in
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lymphatic and hematopoietic (lymphohematopoietic)
malignancies, whereas one study with methodological
limitations showed an effect at high concentrations. Three
long-term inhalation studies (C2 years) with FA exposures
up to 15 ppm for 6 h/day, 5 days/week in mice and rats
neither showed a convincing increase (WHO 2010; Nielsen
and Wolkoff 2010; Golden 2011; Rhomberg et al. 2011).
However, one limitation was that the increased mortality in
the high-exposure groups may have masked an increase in
the lymphohematopoietic malignancies. Adjusting for
increased mortality suggested that if an increase had
occurred, it would occur at C14 ppm (WHO 2010; Nielsen
and Wolkoff 2010; Golden 2011; IARC 2012). For risk
assessment, it was apparent that a potential exposure–
response relationship in rats has to be nonlinear and lym-
phohematopoietic malignancies to be less sensitive endpoints
than SCC (WHO 2010).
Epidemiological studies
Lymphohematopoietic cancers, including leukaemia, did
not increase consistently in three meta-analyses, contrast-
ing ever vs. never exposed (WHO 2010; Nielsen and
Wolkoff 2010). Opposite, a meta-analysis by Zhang et al.
(2009) found increased mRR for all types of cancer com-
bined, for all leukaemia, myeloid leukaemia and multiple
myeloma, but not for Hodgkin and non-Hodgkin lym-
phoma. The study used one RR from each study selected in
the order: peak, average intensity, cumulative exposure and
exposure duration. The RR for the highest level was used
from each study. The meta-analysis was updated for leu-
kaemia [mRR (95 % CI): 1.53 (1.11–2.11)], myeloid leu-
kaemia [2.47 (1.42–4.27)] and lymphatic leukaemia (mRR:
0.95) (Schwilk et al. 2010); studies were selected in the
same hierarchically manner as in the first study except that
‘‘earlier date of hire’’ was added to the list. Also, where a
study provided RRs for different exposure levels, the RR
for the highest level was used. The updated analysis con-
firmed that risk was not increased if contrasting exposed vs.
non-exposed (mRR: 1.07) as found in the previous meta-
analyses. Thus, the differences between the analyses
depend on the selection of the studies (WHO 2010; Nielsen
and Wolkoff 2010; Schwilk et al. 2010). The WHO (2010)
concluded that if lymphohematopoietic malignancies are
due to FA, they may appear at high FA levels, which
exceed the detoxification mechanisms at the portal-of-
entry. This conclusion is conservative as recent toxicoki-
netic studies challenge that FA can reach the bone marrow
or other internal organs. Furthermore, a recent compre-
hensive analysis of 24 cohort and 8 case–control studies for
lymphohematopoietic malignancies neither found consis-
tency across studies nor consistent exposure-dependent
effects of FA (Rhomberg et al. 2011). Another recent and
extensive review of 22 cohort and 17 case–control studies
concluded that the relative risk of lymphohematopoietic
malignancies and FA exposures was close to null, apart
from some isolated exceptions; furthermore, supporting
evidence for dose–response relationships was negligible
(Checkoway et al. 2012).
Four studies provided information about exposure-
dependent effects of FA, three major cohort studies (Cog-
gon et al. 2003; Pinkerton et al. 2004; Freeman et al. 2009)
and the NCI embalmer case–control study (Hauptmann
et al., 2009). None of the three cohort studies showed an
increase in standardized mortality ratio (SMR) for the
different lymphohematopoietic malignancies (WHO 2010;
Nielsen and Wolkoff 2010). The NCI cohort has been
updated three times and none of the updates showed an
increase in SMR for any of the lymphohematopoietic
malignancies (Cole et al. 2010). However, Freeman et al.
(2009) and the previous update by Hauptmann et al. (2003)
subdivided exposures into non-exposed and three FA
exposure categories within the exposure metrics, peak
exposure (estimated and not measured), average intensity
and cumulative exposure. The RR was obtained within
each exposure metric with the lowest exposed group as the
reference group (RR = 1); evaluations looked for signifi-
cantly increased RRs and exposure-dependent trends. The
RRs and trends for the average intensity metric were the
most relevant for setting an indoor guideline value as
indoor air exposures are roughly at constant levels. There
was no consistent significant increase in RR and trend for
all lymphohematopoietic malignancies, for non-Hodgkin’s
lymphoma and for multiple myeloma (Hauptmann et al.
2003; Freeman et al. 2009); data were corrected for 1,006
missing deaths in the Hauptmann et al. (2003) study. In the
highest exposure group (C1 ppm), myeloid leukaemia was
increased (RR (95 % CI): 2.19 (0.9–5.3) in the Haupt-
mann et al. (2003) study and the Freeman et al. (2009)
study [1.61 (0.76–3.39)], but none of the updates showed
an exposure-dependent trend. A significant increase
across studies was only observed for Hodgkin’s lym-
phoma, where a similar risk was observed among the
controls and the lowest FA group (0.1–\0.5 ppm FA)
with an abrupt increase in RR (*2–4) to a plateau level at
the two higher exposure groups; the trends were signifi-
cant in both updates. As Hodgkin’s lymphoma has not
been associated with chemical-induced cancer (known
risk factors include socioeconomic status, family size and
Epstein-Barr virus infection (Herbertson and Hancock
2005; Punnett et al. 2010), it was considered precaution-
ary, if the guideline value was set below 0.5 ppm. A
similar analysis was conducted on the peak exposure
metric and in this case it was concluded that the peak level
had to be below 2 ppm (WHO 2010; Nielsen and Wolkoff
2010).
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The NCI case–control study in embalmers estimated
adjusted ORs for effects of FA and lymphohematopoietic
malignancies (Hauptmann et al. 2009). The main focus was
on myeloid leukaemias, which included one subject with
myeloid leukaemia in the reference group, individuals who
had never embalmed. A more stable analysis was obtained
with 5 myeloid leukaemias in the reference group (per-
formed \500 embalmments); this analysis was not evalu-
ated statistically and the statistical results from the first
(unstable) analysis were adhered to the results of the more
stable analysis. In the more stable analysis, the ORs for
myeloid leukaemia showed little difference in the FA
exposure groups and thus, no exposure-dependent trend
was apparent (Cole et al. 2010; Golden 2011; Nielsen and
Wolkoff 2010; Rhomberg et al. 2011). Furthermore, no
increase in mortality was observed for all lymphohemato-
poietic malignancies, for all myeloid leukaemias, for acute
leukaemias and for nasal cancer (Cole et al. 2010). Overall,
the limitations excluded that the study being used for
hazard identification and risk assessment.
In summary, the WHO (2010) guideline was below
reported the effect levels of lymphohematopoietic malig-
nancies. Taking into account that recent toxicokinetic
studies support that FA does not reach the blood com-
partment or internal organs, including the bone marrow;
this indicates that the WHO guideline is precautionary.
Reproductive and developmental toxicity
These endpoints were not discussed in the previous eval-
uations (WHO 2010; Nielsen and Wolkoff 2010) as indoor
air relevant FA exposures were not considered to reach
internal organs; later supported by recent toxicokinetic
studies. The lack of the effects was supported by a review
and meta-analysis (Collins et al. 2001), which was not
discussed in the evaluations. However, a recent review and
meta-analyses have questioned the conclusion of the first
meta-analysis (Duong et al. 2011), why we evaluate these
endpoints.
Humans
The review by Collins et al. (2001) found that there was no
convincing evidence of reproductive or developmental
toxicity in animal studies at FA exposures by routes, which
were relevant for risk assessment of workplace exposure
levels. Eleven human studies, nearly all comprising
exposed females, were described. Eight studies were
included in an overall meta-analysis, where either the male
or the female individuals were exposed. In this case, there
was no overall association with spontaneous abortions; the
mRR was 1.4 (95 % CI 0.9–2.1). However, combining
potential effects of FA on female and male reproductive
organs and expressing the outcome in females may not be
biologically interpretable due to differences of the sexual
organs and their functions. When the analysis was limited
to the 7 studies with only exposed females, the mRR was
1.6 (0.9–2.7). The studies with exposed females were fur-
ther stratified into studies where exposures were self-
reported [2.0 (1.4–2.8)] and obtained from work tasks [0.7
(0.5–1.0)]; self-assessment has a low reliability compared
with job-exposure matrix-based assessments (Burdorf et al.
2011). This suggests that the increased risk may be due to
recall bias. Neither was birth defect nor was low birth
weight associated with FA exposures, but infertility was
increased. However, the few studies were considered
insufficient to reach robust conclusions. A single study was
evaluated where only the males were exposed and the
outcome studied was spontaneous abortion (mRR: 1.0
(0.8–1.4) for high exposed men) (Lindbohm et al. 1991),
see below. All included studies had at least one potential
confounding exposure (Collins et al. 2001). This is
expected to increase the observed RR independent of the
FA exposures.
An opposite conclusion was reached in a recent sys-
tematic review, including meta-analyses (Duong et al.
2011). This review describes 18 human studies, but only
one was published in the period between the two reviews.
This study investigated pregnancy outcome among 1,025
female laboratory technicians and 8,037 female teachers
(the reference group) from the Danish National Birth
Cohort (1997–2003) using a follow-up study design (Zhu
et al. 2006); a job-exposure matrix was used in the expo-
sure assessment and an exposure index was used to classify
exposures into three groups: the unexposed reference group
(OR = 1), the lower exposure levels and the highest
exposure level. No difference was found in preterm birth
(lower exposures: 1.0 (95 % CI 0.5–2.0) and highest
exposure [0.7 (0.3–1.7)], small for gestational age
[1.2(0.7–2.0) and 1.2 (0.6–2.2), respectively] and ‘‘major’’
malformations [1.2 (0.6–2.1) and 1.5 (0.8–2.9), respec-
tively]. In contrast, work with radioimmunoassay and
radiolabelling were associated with adverse pregnancy
outcome, lending support to the outcomes being plausible.
Overall, this study does not suggest developmental effects
of FA.
The first meta-analysis by Duong and co-workers
included seven studies and addressed spontaneous abortion
exclusively in FA-exposed female employees. The mRR
(95 % CI) was 1.76 (1.29–2.41), indicating a significant
increase. However, if the mRR was obtained from studies
where exposures were assessed by other than self-reports to
minimize recall bias, the risk was no longer significantly
increased [1.29 (0.52–3.21)]. The recent analysis was
similar to the study of Collins and co-workers, except that
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the highest exposure group was included where available.
Further, the study by Stu¨cker et al. (1990) in the analysis by
Collins [(OR (95 % CI): 1.0 (0.5–2.0)] was replaced by a
study of Saurel-Cubizolles et al. (1994) [crude OR: 1.68
(1.01–2.82)]; the latter accounted for 37.2 % of the weight
in the first meta-analysis by Duong et al. (2011).
The Stu¨cker study investigated the RR (95 % CI) of
spontaneous abortion among nurses working with cyto-
statics, where the control group was non-exposed nurses.
The exposure to cytostatics was associated with an
increased risk [1.7 (1.2–2.5)]. A similar comparison after
exclusion of all FA-exposed nurses resulted in a slightly
higher risk estimate [2.1 (1.3–3.4)] and thus, FA exposure
did not add to the spontaneous abortion risk. In the other
study, the pregnancy outcome was investigated in female
operating room nurses in hospitals in Paris (Saurel-Cubi-
zolles et al. 1994); the control group conducted no
operating room work. Exposure assessment was from self-
reported exposure to anaesthetics (yes/no), ionizing radia-
tion (yes/no), FA (yes/no) and antineoplastics (yes/no).
Such an assessment method has low reliability (Burdorf
et al. 2011). The crude OR was significantly increased for
spontaneous abortion among nurses exposed to anaesthet-
ics, ionizing radiation and FA [OR (95 % CI): 1.7
([1.0–2.8)], which was not adjusted for the two other
exposures. This value was an overestimate as it was men-
tioned that ‘‘the exposure during pregnancy were closely
interrelated: exposures to FA and to ionizing radiation were
much more common among pregnancies exposed to ana-
esthetics than among non-exposed pregnancies: 84 and
64 %, respectively, compared with 20 % (p \ 0.001) and
11 % (p \ 0.001).’’ Furthermore, after adjustment for
confounding factors (age, number and outcome of previous
pregnancies, smoking and exposure to antineoplastic
drugs), the OR increased [2.6 (1.3–5.2)], if the exposure
included all three risk factors (anaesthetics, FA and ion-
izing radiation). The OR did not increase [0.9 (0.4–1.8)]
with only one or two risk factors. Thus, the crude OR from
this study and its high weighting (37.2 %) in the meta-
analysis will artificially increase the mRR risk; the appro-
priate value should be much closer to unity and thus similar
to the value in the Stu¨cker study.
The second meta-analysis by Duong et al. (2011) com-
prised 12 studies and it included all reproductive and
developmental outcomes combined, where a single out-
come was selected from each study in the order: sponta-
neous abortion, birth defects or malformations and low
birth weight. The risk estimate from the highest exposure
group was used where available. The mRR was signifi-
cantly increased [1.54 (1.27–1.88)]. The analysis has sev-
eral limitations, because the combination of different
endpoints may not be interpretable since the effect of dif-
ferent endpoints may be independent (Carmines and
Rajendran 2008). Furthermore, the analysis combined
occupational and environmental exposures. In the three
environmental studies included, the FA exposures may
exceed 5 lg/m3, but the majority of the exposures were
lower. The environmental studies had ORs from 1.24 to
2.09 and their weight in the analysis was 47 %. The ORs in
the occupational studies was from 0.87 to 3.5. The similar
ORs with different exposure levels violate the paradigm
about exposure–response relationships. Also, the FA
exposure levels in the environmental studies were similar
to reported levels of FA in exhaled breath. Selection within
studies is problematic. For example, in the Zhu et al.
(2006) study, the non-significant ORs from the highest
exposure group is available from three endpoints, preterm
birth (OR: 0.7), small for gestational age (OR: 1.2) and
‘‘major’’ malformation (OR: 1.5). In the meta-analysis,
only the highest value was taken into account and the other
non-significant values were disregarded. This may cause
selection bias against a higher mRR. Thus, this meta-
analysis is uninterpretable and cannot be used for hazard
identification and setting an indoor guideline value for FA.
Overall, the results from the meta-analysis by Collins
et al. (2001) and the first meta-analysis by Duong et al.
(2011) are not substantially different. No significant
increase is observed in studies with low recall bias. A
somewhat increased mRR, that was observed in both
studies, can freely be explained by the lack of confounder
control as indicated from the crude OR (1.7) and the
adjusted OR (0.9) in the study of Saurel-Cubizolles et al.
(1994). Thus, no convincing effect of FA was observed in
pregnant women in agreement with the toxicokinetic
studies indicating that FA does not reach the internal
organs.
The effect of FA exposure on paternal fertility has only
been studied to a limited extent. A nationwide register-
based study addressed chemical risk factor for spontaneous
abortion in 99186 pregnancies in Finland. Both the male
and the female occupation and industry were used for
exposure classification, comprising ‘‘none’’, ‘‘potentially
low’’ and ‘‘moderate or high’’. The analysis also included
socioeconomic status, age and maternal exposure to
reproductive toxicants. For paternal exposure, no associa-
tion was observed with low FA exposure [OR (95 % CI):
1.1 (0.9–1.4)] and moderate or high exposure [1.0
(0.8–1.4)], but increased risks were associated with pater-
nal exposure to ethylene oxide, solvents, rubber chemicals
and rubber products. The study was not able to address
potential confounding by alcohol consumption and smok-
ing (Lindbohm et al. 1991). Nevertheless, it supports that
no effect on male fertility is expected at the indoor
guideline level.
Paternal exposure to FA and effects on reproduction was
evaluated in a case–control study, where endpoints were
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time to pregnancy (TTP), spontaneous abortion, preterm
birth, sex ratio and major structural birth defects (Wang
et al. 2012). Effects were obtained from a questionnaire
presented to the males. For inclusion in the case group,
1,035 employees in the wood processing industry were
screened and 302 (29.2 %) were accepted as cases. A group
of 816 males, mainly salesmen and clerks, were screened
for the control group; 305 (37.4 %) were accepted. Thus,
both groups were highly selected. Exclusion criteria
included that a couple had genital malformations or other
chronic diseases; 16.7 % were excluded for participating in
the case group and 7.1 % for the control group. Exclusion
due to unknown TTP and other uncompleted questionnaires
were 11.3 % for inclusion in the case group and 16.8 % for
the control group. This suggests different health status and
different recall in the groups. In the case group, 88.1 %
smoked and 85.3 % smoked in the control group, that is,
both groups consisted mainly of smokers. In the case
group, the odds ratio (95 % CI) was significantly increased
for TTP ([2.8 (1.1–7.4)]; adjusted for body mass index and
alcohol consumption) and for spontaneous abortion ([1.9
(1.1–3.3)]; adjusted for smoking). FA exposure did not
increase preterm birth, low birth weight, skewed sex ratio
distribution and birth defects. In general, self-assessment
may have a limited reliability (Burdorf et al. 2011). Lim-
itations of the study include the high selection of the
groups, an unusual high smoking prevalence in both
groups, lack of reported FA levels although measured and
the lack of description of the females in the two groups. For
example, TTP depends on the age, the educational level,
parity (first vs. second child) and smoking among the
females (Burdorf et al. 2011). Most important, no con-
founder control was carried out for other chemicals.
Overall, the study cannot be used for hazard identification
of indoor air FA exposures on male reproduction.
Although the effect of FA exposure on male reproduc-
tion has been studied only to a limited extent, there is no
convincing indication that it is affected. This is further
supported from toxicokinetic studies, which show that FA
does not reach internal organs.
Animal studies—frame of interpretation
Evaluation of reproductive and developmental effects of
FA has to consider other toxicological effects (reflex bra-
dypnea, decreased body temperature, reduced oxygen
supply and reduced nasal mucociliary clearance) as well as
stress-induced reactions (NRC 2011). First, high concen-
trations of FA induce strong eye and upper airway irrita-
tion. Thus, the concentration decreasing the respiratory rate
by 50 % (RD50) in mice due to activation of a protective
trigeminal reflex is considered ‘‘intolerable in humans’’
(Kane et al. 1979). The RD50 in mice is about 4 ppm; the
respiratory rate begins to decrease already at 0.3 ppm
(Chang et al. 1981; Nielsen et al. 1999). Thus, exposures in
animals from 4 ppm and above induce strong eye and
airway irritation and thus, exposure-dependent pain-
induced stress reactions are expected. As the tidal volume
up to about 4 ppm FA in mice is virtually constant, the
respiratory ventilation is halved at the RD50, resulting in
decreased oxygen supply in mice and presumably hypoxia-
induced stress reactions. The effect on respiratory rate and
respiratory ventilation were less pronounced in rats. The
decrease in respiratory ventilation at repeated exposure to
2, 6 and 15 ppm was about 20, 25 and 30 %, respectively
(Chang et al. 1981, Fig. 5). A decrease in the respiratory
ventilation of 50 % required about 50 ppm FA (Chang
et al. 1981). The pronounced decrease in minute volume in
mice compared with that in rats was confirmed in a study
with 15 ppm FA exposure. This was associated with a
reduced steady-state CO2 exhalation of 42 % of that in the
control mice, whereas CO2 exhalation in rats transiently
decreased to 76 % of that in the control group. Thus, the
decreased ventilation was associated with a decrease in
metabolism. Additionally, the body temperature decreased
from 37.8 to 34.7 C in mice and from 37.3 to 36.8 C in
rats (Jaeger and Gearhart 1982). Overall, the decreased
respiratory ventilation may cause hypoxia-induced stress.
Stress-induced effects can be suggested from different
stress models. Restraint is used as a standard model in
rodents. In pregnant mice, restraint may cause implemen-
tation failure, cleft palate, supernumerary ribs and resorp-
tion; adrenocortical hormones have been implicated in the
stress-induced induction of cleft palate, but not on super-
numerary ribs, and implantation failure. In pregnant rats,
there is some evidence for restraint-induced implantation
failure, but not for morphological anomalies (Golub et al.
2004). Long-term hypoxaemia in sheep decreased the
function of the hypothalamic–pituitary–adrenal axis at the
adrenal gland level in the foetuses that had a decreased
ability to respond with cortisol production. The adrenals
play a key role in the initiation of labour and, therefore, the
adaptation may play an important role in a prevention of
preterm delivery at chronic stress. In rats and sheep,
hypoxia decreased the contractile response of the myo-
metrium to oxytocin due to a decrease in the oxytocin
receptor level (Ducsay 1998). Thus, in pregnant animals
several mechanisms may blunt stress-induced adverse
developmental outcome.
In men, stress may suppress spermatogenesis, decrease
testosterone levels and change testicular blood flow. In rats
and mice, stress induced by immobilization or surgery
decreased testosterone and increased corticosterone levels
(McGrady 1984). In general, terrestrial animal tissue
exposed to prolonged fasting, hypoxia and ischaemia/
reperfusion responds with oxidative stress and tissue
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damage (Liu et al. 2011; Va´zquez-Medina et al. 2012),
which at least partly depend on the tissue antioxidant level
(Va´zquez-Medina et al. 2012). Thus, hypoxia due to
chronic obstructive pulmonary diseases in men decreased
serum testosterone levels (Aasebø et al. 1993) and caused
atrophy of the testosterone producing Leydig cells (Gosney
1987). Also, unacclimatized men exposed for 4 weeks to
high altitude induced hypoxia resulted in a decrease in
sperm counts and mobility, and an increase in abnormal
forms (Donayre et al. 1968) Hypobaric hypoxia has been
shown to cause testicular degeneration in monkeys and rats
(cf. Cikutovic et al. 2009). In one study, male rats were
housed 7 days at 3 km altitude followed by 7 days at sea
level, a cycle repeated 6 times. The control group was
housed at sea level. The hypoxic rats had decreased tes-
ticular diameter of the tubules and decreased thickness of
the spermatogenic epithelium compared with that in the
controls. The cauda epididymis sperm concentration in the
hypoxic males was decreased to 20 % of the controls
(Cikutovic et al. 2009). At least partly, these effects were
due to changes in the hypophysis–gonad axis as 30 days
with hypobaric hypoxia in rats decreased the plasma
luteinizing hormone level, which causes a decrease in
Leydig cell stimulation, and thereby a decrease in the
plasma testosterone level and the height of the spermato-
genic epithelium (Farias et al. 2008). In rats, treatment with
ascorbic acid prevented the hypobaric hypoxia-induced
decrease in epididymal sperm count and increase in tes-
ticular and epididymal lipid peroxidation; this suggests that
oxidative stress plays a role in these effects (Farias et al.
2010). In contrast, hypoxia induced by 12 % oxygen in the
air, 8 h/day for 4 days in rats increased the plasma tes-
tosterone level and its release forms the Leydig cells
(Hwang et al. 2009). However, the short-term effects are
not considered as they are not relevant for the evaluation of
the longer lasting studies described below. Overall, dif-
ferent types of stress may have profound adverse effects on
male testis.
The previously conducted long-term studies (C2 years
of FA exposure for 6 h/day, 5 days/week) in male and
female rats (group size about 100 animals per sex) with up
to 15 ppm FA concentrations did not mention specific
effects on sexual organs, but Kerns et al. (1983) mentioned
no effect outside the upper airways in males and females
where ‘‘all major tissues from each organ system’’ were
investigated. Sellakumar et al. (1985) mentioned no effect
on the testes, which were included in the histopathology;
the study included only male rats.
Exposure of female rats
A developmental toxicity study was conducted in rats
exposed to 5, 10, 20 or 40 ppm FA for 6 h/day from
gestational day 6–20, and with caesarean section on day
21; each group contained 25 rats. None of the dams died,
but the body weight gain was significantly decreased
(halved) in the 40 ppm group. The mean implantation sites/
litter, mean total foetal loss/litter, mean resorption sites/
litter, mean live foetuses/litter and foetal sex ratio were
similar in all groups. However, the male foetal body weight
was significantly decreased in the 20- and 40-ppm groups,
whereas the female foetal body weight gain decreased only
in the 40-ppm group. External, visceral and skeletal
examinations of the foetuses did neither reveal major
abnormalities nor were there any difference in other soft-
tissue and skeletal variations, such as dilated ureter, extra
fourteenth ribs, rudimentary thirteenth ribs and delayed
ossification of thoracic vertebrae (Saillenfait et al. 1989).
Thus, a decreased body weight gain was observed in the
dams at the highest exposure level (40 ppm), but no effect
was observed at 20 ppm (NOAEL). A slight foetotoxic
effect (reduced weight in male foetuses) was observed with
an NOAEL at 10 ppm. No teratogenic effect was observed
(NOAEL: 40 ppm).
Another developmental toxicity study was conducted in
rats exposed to 2, 5 or 10 ppm FA for 6 h/day from ges-
tational day 6 to 15; each group contained 25 rats. Two
control groups were included: one was air exposure and in
the other was maintained in the animal room throughout
the study. No maternal death occurred. The maternal food
consumption was significantly decreased in the 10-ppm
group. Formaldehyde exposure had no effect on numbers
of corpora lutea, implantation sites, live foetuses, dead
foetuses and resorptions, foetal weights, sex ratios and pre-
and post-implantation losses. ‘‘The incidences of reduced
ossification of pubic and ischial bones in the 5 and 10 ppm
treated groups were significantly increased when compared
to the air control group but not the room control group.
These findings were considered to be related to slightly
larger litter sizes and slightly lower foetal weights in the 5
and 10 ppm treated groups’’ (Martin 1990). This study
showed an NOAEL for maternal toxicity (reduced food
consumption) at 5 ppm and no teratogenic effect at
10 ppm. The study, although only briefly reported, is in
overall agreement with Saillenfait et al. (1989), except that
the NOAEL for maternal toxicity appears to be somewhat
lower (5 ppm).
Also, the lack of effect of FA exposures on female rat
pregnancy outcome was reported in a recent study (Car-
mines and Rajendran 2008). Pregnant rats were exposed
nose-only for 2 h/day on gestational days 6–19 to an
aldehyde mixture or to air. Caesarean sections were per-
formed on day 20; each group contained 27 dams. The
aldehyde mixture contained 1 mg/m3 FA (0.8 ppm),
41 mg/m3 acetaldehyde (23 ppm) and 4 mg/m3 acrolein
(1.7 ppm). The mixture and thus FA did not affect maternal
Arch Toxicol (2013) 87:73–98 91
123
body weight gain, food consumption and mean uterine
weight. Neither was viable litters, live foetuses per litter,
resorptions per litter, mean foetal weight nor foetal sex
ratio affected. No external malformations (micrognathia/
agnathia, umbilical hernia or filamentous tail) were
observed. This study also investigated interactions between
compounds affecting different developmental toxicity
endpoints. Inhalation of nicotine decreased the pregnant rat
body weight gain, but it did not affect the foetal body
weight. Opposite, carbon monoxide [*30 % carboxyhe-
moglobin (COHb)] had no effect on the maternal body
weight gain, but decreased foetal body weight; COHb may
have compromised oxygen supply to the foetus. The
aldehyde mixture had no effect on the maternal weight gain
or the foetal body weight. Binary and ternary mixtures of
these exposures showed no interaction of the exposure
effects on the weights. Thus, this study suggests that
developmental toxicity endpoints have to be evaluated
separately.
Embryo culture studies show that FA can induce severe
embryotoxicity, including death (Hansen et al. 2005).
However, as such effects were not observed in inhalation
studies with exposures up to 40 ppm, this indicates that FA
does not reach the embryo by inhalation.
Several Russian inhalation studies with exposures from
0.01 to 1.2 ppm in female rats showed adverse reproduc-
tive and developmental outcomes (Thrasher and Kilburn
2001), however, with unusual methods. These results are
inconsistent with the above-reviewed studies, which
showed no teratogenic effect up to 40 ppm in spite of
potential pain-induced and hypoxia-induced stress.
Exposures of male rats
Adult male rats were exposed for 8 h/day, 5 days/week for
4 and 13 weeks to 0 (controls), 12.2 and 24.2 mg/L; the
concentrations are probably in mg/m3 and thus, equal to 10
and 20 ppm, respectively, as the US NIOSH analytical
method was used for calibration. Each group contained 7
rats. In the 4-week study, the body weight gain was 30 and
13 %, respectively, and the testis weights 98 and 97 %,
respectively, in the low and high FA groups compared with
that of the control group. The corresponding concentrations
of metals in the testis were 48 and 39 % for Zn, 66 and
52 % for Cu and 117 and 130 % for Fe. In the 13-week
study, the body weight gain was 62 and 37 %, respectively,
and the testis weight 92 and 90 %, respectively. The
respective testis content of Zn was 42 and 35 %, of Cu 60
and 32 % and of Fe 158 and 176 %. The authors concluded
that the altered metal levels may induce oxidative damage
of testicular tissue (Ozen et al. 2002).
In groups of rats (N = 6) exposed 8 h/day, 5 days/week
to 0 (controls) at 5 or 10 ppm for 13 weeks, ‘‘unsteady
breathing, an increase in nose cleaning, excessive licking,
frequent sneezes, and haemorrhage in the nasal mucosa’’
were observed. However, there was no mortality in the
groups. Food and water consumption were relatively
decreased in the FA groups. In the low and high FA
exposure groups, the serum testosterone concentration was
significantly decreased to 60 and 35 %, respectively, of
that in the control group. It was proposed that the decrease
was due to a dysfunction of the hypothalamic–pituitary–
gonadal axis. Furthermore, the mean seminiferous tubule
diameter was significantly decreased to 91 and 90 %,
respectively, in the FA groups. Immunohistochemistry
showed exposure-dependent increase in heat shock protein 70
in spermatogonia, spermatocytes and spermatids, but without
heat shock protein in Sertoli cells (Ozen et al. 2005).
In a 2-week study, male rats were exposed to 10 mg/m3
FA (8 ppm) for 12 h/day; the control rats were exposed
orally to physiological saline. Each group contained 10
rats. In the FA group, the testicular weight was signifi-
cantly decreased. Histopathology showed atrophy of the
seminiferous tubules, decrease in spermatogenic cells,
seminiferous epithelial cell disintegration and shedding
into the lumen, interstitial tissue oedema with vascular
dilatation and hyperaemia. Luminal azoospermia was
observed. Epididymal sperm counts were decreased as was
percentage of motile sperm. Abnormal sperm counts were
increased in the FA group. The testicular superoxide dis-
mutase, glutathione peroxidase and glutathione level were
significantly decreased, and the malondialdehyde level was
significantly increased. A daily oral administration of
30 mg/kg/day vitamin E in the exposure period blunted the
adverse effects of FA, suggesting that the effects were due
to oxidative stress (Zhou et al. 2006).
In a recent study in male rats, the effects of 0 (controls),
0.5 and 2.46 mg/m3 FA (0, 0.4 and 2 ppm, respectively)
for 8 h/day for 60 consecutive days were investigated; each
group comprised 10 animals. The groups showed no clin-
ical difference. Neither was differences observed in serum
testosterone concentrations, in testicular and epididymal
weights, nor in epididymal tubular diameters. However, in
the high-exposure group, atrophy of the testicular semi-
niferous tubules, decreased spermatogenic cells and oli-
gozoospermia were observed. Epididymal lumina were
also oligozoospermic. Additionally, testicular seminiferous
tubular diameter, superoxide dismutase and glutathione
peroxidase and epididymal sperm count were significantly
decreased. Testicular malondialdehyde and epididymal
percentage of abnormal sperm were significantly increased.
No difference was found between the control group and the
0.5 mg/m3 group (Zhou et al. 2011). Thus, the NOAEL
was 0.4 ppm and the LOAEL 2 ppm.
Inhalation is the relevant route of exposure for setting an
indoor air guideline. None of the above-mentioned
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inhalation studies interpreted the FA-induced testicular
effects in context of known biological effects of FA; thus,
the prominent clinical symptoms apparent at 5 ppm agree
with expected occurrence of severer irritation-induced
stress. Also, 5 ppm decreased food and water consumption
that may reasonably explain the observed decrease in body
weight gain at 10 ppm. At 10 ppm, the testicular levels of
Zn and Cu were decreased that may be due to one or more
of the potential indirect mechanisms causing testicular
damage; these include stress from irritation, hypoxia and
reduced intake of food. The latter may cause insufficient
supply of the metals. The increased Fe would be in line
with an increase in hyperaemia in the testes, which was
observed at 10 mg/m3 (8 ppm) FA. The LOAEL (2 ppm)
was a level that causes moderate sensory irritation-induced
stress and hypoxia-induced stress (20 % decrease in
respiratory minute volume); higher levels caused exposure-
dependent increase in testicular effects. At the LOAEL, no
increase is expected in FA absorption. The NOAEL was
0.4 ppm where neither sensory irritation nor decreased
respiratory minute volume was observed; no effect was
observed in the absence of sensory irritation, which is the
case at the indoor air guideline value. Further, recent tox-
icokinetic studies do not support that FA reaches the sexual
organs.
Evaluation of risk from indoor air formaldehyde
The WHO (2010) approach
The WHO approach used sensory irritation of the eyes and
the upper airways as the critical effect. The most com-
prehensive controlled chamber study was used for setting
the guideline value, 0.1 mg/m3 for each 30-min period of
the day. This result agreed with previous studies and fur-
ther supported by a recent chamber study. The value is also
to be considered a long-term guideline value as sensory
irritation was not considered to increase at repeated expo-
sures as found in a recent mouse study. In contrast, epi-
demiological studies were not considered sufficiently
robust for setting a guideline value on sensory irritation due
to insufficient confounder control. Furthermore, the
guideline value was considered to protect against nasal
cancer based on the analysis of the mode-of-action, the
nonlinear concentration–response relationship, the occur-
rence of an apparent NOAEL and two risk assessment
approaches. They were based on an assessment factor
approach. The results from the assessment factor approa-
ches were strongly supported by a biologically based dose–
response model, which is one of the best-developed models
today for any chemical, even with its uncertainties (NRC
2011). All models suggested that there was no risk of nasal
cancer at the guideline level established from sensory
irritation; this is supported from recent toxicokinetic stud-
ies. These studies showed that, exogenous FA-induced
DNA adduct levels in the nose are marginal in comparison
with adduct levels generated from endogenously formed
FA at low concentrations. Lymphohematopoietic cancer
was suggested from epidemiological studies. Analyses of
concentration–response relationships showed that if caused
by FA, effects occurred at high-exposure levels and
exposure–response relationships were nonlinear, and pre-
vention of nasal cancer would also prevent lymphohemat-
opoietic malignancies, including leukaemia. However,
recent toxicokinetic studies have shown that FA is not
absorbed beyond the respiratory tract and thus, questions
that FA can reach the bone marrow and cause leukaemia.
Altogether, the WHO (2010) guideline value is not con-
tradicted, but rather supported by recent studies.
The French approach
France has two indoor air guidelines (AFSSET 2007). A
short-term exposure level has been set to 50 lg/m3 over
2-h periods; it was based on a study of Pazdrak et al.
(1993). A long-term exposure level was set to 10 lg/m3,
which was based on a study of Holmstro¨m et al. (1989).
The values have recently been used in a study of the risk of
FA exposure in the French population (Mandin et al. 2012).
Additionally, France has set long-term standards for public
buildings at 30 lg/m3 from 1 January 2015 with a further
reduction to 10 lg/m3 from 1 January 2023 (De´cret 2011)
In the study of Pazdrak et al. (1993), nine patients with
skin hypersensitivity to FA were compared with 11 healthy
volunteers in a 2-h study with an exposure at 0.5 mg/m3
FA; all subjects were non-smokers. The study parameters
were the combined nasal symptom score from sneezing,
mucosal oedema, rhinorrhea and eye itching, and the nasal
lavage fluid (NALF) content of eosinophils, basophils,
epithelial cells, neutrophils and mononuclear cells as well
as albumin and total protein content. Pre-exposure levels
were used for exposure-effect assessment, which was
studied up to 16-h post-exposure. The pre-exposure
parameters were similar in the groups; exposure to clean air
showed no effect. In both groups, the combined symptom
score increased in a similar manner after the exposure
(roughly 2–10 times) and decreased in a similar manner in
the post-exposure period; the increase was still significant
at the end of the period. In both groups, the NALF content
of eosinophil counts approximately doubled after the FA
challenge. The counts decreased in the post-exposure per-
iod, but they were still significantly increased at the end of
the period. The NALF content of albumin and total protein
followed a similar pattern as the eosinophils. The epithelial
cell fraction was significantly decreased in both groups,
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whereas no effect was seen on the fraction of basophils,
neutrophils and mononuclear cells and the content of
tryptase. The authors stated that there was no difference in
NALF parameters between the groups. Additionally, it was
stated that the FA exposure caused a ‘‘transient burning
sensation of the eyes and the nasal passages’’. Recent high-
quality chamber studies do not find adverse symptoms at
0.5 mg/m3, except for odour; they might have occurred if
high peak exposures were present. However, from the
comparable effects in individuals with and without skin
hypersensitivity (type IV) reactions, it can be concluded
that type IV skin allergic individuals are not a sensitive
group at FA exposures.
In a second study by the same group, 10 workers with
asthma, ascribed to FA, and 10 healthy workers were
exposed to 0.5 mg/m3 FA for 2 h and followed for up to
24 h post-exposure. Clean air exposure did not induce
symptoms or influenced the nasal parameters. Symptoms
(sneezing, itching and nasal congestion) were similar in the
two groups and highest immediately after the inhalation of
FA; the scores were roughly similar to that in the first
study. In both groups, leucocytes counts in NALF were
similar and roughly doubled immediately after the provo-
cation, but only significant in the healthy workers. The
eosinophil counts followed a similar pattern and was sig-
nificantly increased in both groups. The protein concen-
trations were less than doubled; significance testing was
not reported. Eosinophil cationic protein and tryptase
concentrations in NALF were not affected significantly. No
effect of FA was observed on forced expiratory volume in
1 s (FEV1), peak expiratory flow (PEF) and lung function
at histamine challenge. None of the asthmatics has FA
specific IgE antibodies. The authors interpreted the findings
as a transient and non-specific reaction that was similar in
asthmatics and non-asthmatics (Krakowiak et al. 1998).
Neither this study described the FA generation system.
However, from a risk assessment point of view, it can be
concluded that subjects with asthma do not constitute a
sensitive group.
The short-term French reference exposure guideline
value was derived by setting the LOAEL to 500 lg/m3
based on the first study. An assessment factor (AF) of 3
was used because the point of departure was the LOAEL.
An additional AF of 3 was included for protection of
sensitive individuals; neither the reason for including this
AF nor its size was substantiated.
The French long-term guideline value was based on a
study of Holmstro¨m et al. (1989), which investigated nasal
histopathology in two groups of workers: one group was
from a chemical plant and the other group comprised wood
workers. From this study, the LOAEL was considered to be
0.3 mg/m3. An AF of 3 was used for departing from the
LOAEL and an AF of 10 was used for intrahuman
variability (AFSSET 2007). In the chemical plant workers,
the median FA concentration was 0.3 mg/m3 with frequent
peak exposures above 1 mg/m3. In the furniture industry,
the FA concentration was in the range 0.2–0.3 mg/m3 in
general and seldom exceeded 0.5 mg/m3; wood dust
exposures were up to 4.9 mg/m3. The mean concentration
in the control group was 0.09 mg/m3 FA. The mean nasal
biopsy score was 1.56 (range 0–4) in the controls, 2.07
(range 0–6) in the furniture workers (not statistically sig-
nificant) and 2.16 (range 0–4) in the chemical plant (sta-
tistically significant); the grading scores were from 0 to 8.
The FA levels were divided into exposure levels for current
exposure and cumulative exposure; they showed no expo-
sure-dependent trend. The limitations, including high peak
exposures, confounding by wood dust and lack of expo-
sure-dependent effects, hinder that the study can be used
for deriving a guideline value (WHO 2010). Recently, the
National Research Council reached a similar conclusion
based on a comprehensive evaluation (NRC 2011).
Overall, the French guideline values cannot be consid-
ered reliable alternatives to the WHO (2010) guideline
value.
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